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A B S T R A C T
Background
This review considers the use of day hospitals as an alternative to outpatient care. Two types of day hospital are covered by the review:
’day treatment programmes’ and ’transitional’ day hospitals. Day treatment programmes offer more intense treatment for people who
have failed to respond to outpatient care. Transitional day hospitals offer time-limited care to people who have just been discharged
from inpatient care.
Objectives
To assess effects of day hospital care as an alternative to continuing outpatient care for people with schizophrenia and and other similar
severe mental illness.
Search methods
We searched the Cochrane Schizophrenia Group Trials Register (May 2009) and references of all identified studies for further citations.
If necessary, we also contacted authors of trials for further information.
Selection criteria
Randomised controlled trials comparing day hospital care with outpatient care for those with schizophrenia and other similar severe
mental illness.
Data collection and analysis
We extracted and cross-checked data independently. We analysed dichotomous data using fixed-effect relative risk (RR) and estimated
the 95% confidence interval (CI). If continuous data were included, we analysed this data using the random-effects weighted mean
difference (MD) with a 95% confidence interval.
1Day hospital versus outpatient care for people with schizophrenia (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Main results
We identified four relevant trials all dating from before 1986 (total n=309 participants); all but one of which (n=37) evaluated day
treatment centres. Across time less people allocated to day hospital care tend to be admitted to hospital (beyond one year: n=242, 2
RCTs, RR 0.71 CI 0.56 to 0.89 day treatment centres) but data are heterogeneous (I2 =74% P=0.05) and should not be taken into
account. Data on time spent as an inpatient seem to support this finding but are poorly reported. We found no clear difference between
day hospital and outpatient care for the outcome of ‘lost to follow up’ (at six months: n=147, 3 RCTs, RR 0.97 CI 0.48 to 1.95; at 12
months: n=117, 2 RCTs, RR 0.97 CI 0.48 to 1.95 day treatment centres / transitional day hospital). Scale derived findings on social
functioning are equivocal (SAS: n=37, 1 RCT, MD 0.36 CI -0.07 to 0.79 transitional day hospital) but there was some suggestion
from small studies that day hospital care may decrease the risk of unemployment (at 12 months: n=80, 1 RCT, RR 0.86 CI 0.69 to
1.06 day treatment centre). Different measures of mental state showed no convincing effect (Symptom Check List: n=30, 1 RCT, MD
-90 0.31 CI -0.20 to 0.82 day treatment centre). Poorly reported economic data from decades ago suggested that day hospitals were
more costly to establish and run than outpatient care but took no account of other costs such as inpatient stay.
Authors’ conclusions
Evidence is limited and dated. Day hospital care may help avoid inpatient care but data are lacking on missing on a raft of outcomes
that are now considered important, such as quality of life, satisfaction, healthy days, and cost.
P L A I N L A N G U A G E S U M M A R Y
Day hospital versus outpatient care for people with schizophrenia
Psychiatric day hospitals offer care that is less restrictive than inpatient care but more intense than outpatient care. Day hospitals
can be used to provide more intense/specialised outpatient care to people resistant to treatment (day treatment programmes) or to
those needing long-term care (day care centres). They can also bridge the gap between inpatient and outpatient care (transitional
day hospitals). This review compared day hospital care (in day treatment centres and transitional day hospitals) to outpatient care.
Overall there was insufficient evidence to determine whether any of the three types of day hospital care had substantial advantages over
outpatient care.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
DAY HOSPITAL versus OUT-PATIENT CARE for people with schizophrenia near or on discharge
Patient or population: patients with people with schizophrenia near or on discharge
Settings: high income countries
Intervention: DAY HOSPITAL versus OUT-PATIENT CARE
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control DAY HOSPITAL versus
OUT-PATIENT CARE
Service use: 1a. Admit-
ted to hospital during
study - by 6 months
Study population RR 0.58
(0.26 to 1.33)
110
(2 studies)
⊕⊕⊕©
moderate1
See ’Effects of interven-
tions’ 1.3
218 per 1000 126 per 1000
(57 to 290)
Medium risk population
150 per 1000 87 per 1000
(39 to 200)
Service use: 1b. Admit-
ted to hospital during
study - by/at 12 months
Study population RR 0.73
(0.54 to 1)
242
(2 studies)
⊕⊕©©
low2,3
See ’Effects of interven-
tions’ 1.3
467 per 1000 341 per 1000
(252 to 467)
Medium risk population
469 per 1000 342 per 1000
(253 to 469)
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Service use: 1c. Ad-
mitted to hospital dur-
ing study - beyond 12
months
Study population RR 0.71
(0.56 to 0.89)
242
(2 studies)
⊕⊕⊕©
moderate4
See ’Effects of interven-
tions’ 1.3
639 per 1000 454 per 1000
(358 to 569)
Medium risk population
623 per 1000 442 per 1000
(349 to 554)
Global state: 1a. Number
lost to follow up - by 6
months
Study population RR 0.97
(0.48 to 1.95)
147
(3 studies)
⊕⊕⊕©
moderate5,6
See ’Effects of interven-
tions’ 1.2
164 per 1000 159 per 1000
(79 to 320)
Medium risk population
100 per 1000 97 per 1000
(48 to 195)
Global state: 1b. Number
lost to follow up - by/at
12 months
Study population RR 0.97
(0.48 to 1.95)
117
(2 studies)
⊕⊕©©
low2,6
See ’Effects of interven-
tions’ 1.2
207 per 1000 201 per 1000
(99 to 404)
Medium risk population
272 per 1000 264 per 1000
(131 to 530)
Social functioning: 2a.
Unemployed - by 6
months
Study population RR 0.04
(0 to 0.62)
30
(1 study)
⊕⊕©©
low6,7
See ’Effects of interven-
tions’ 3.2
800 per 1000 32 per 1000
(0 to 496)
Medium risk population
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800 per 1000 32 per 1000
(0 to 496)
Social functioning: 2b.
Unemployed - beyond 12
months
Study population RR 0.86
(0.69 to 1.06)
80
(1 study)
⊕⊕⊕©
moderate8
See ’Effects of interven-
tions’ 3.2
875 per 1000 752 per 1000
(604 to 927)
Medium risk population
875 per 1000 752 per 1000
(604 to 927)
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 One study provides no details on concealment or blinding
2 No explanation provided
3 I2 >50%
4 I2 >70%
5 One study provides no details on allocation concealment, the study was not blinded by design
6 Small study/studies and overall total
7 Day care centre provided participants with jobs
8 Blinding was attempted, but not adequate
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B A C K G R O U N D
Since the 1960s there has been an almost worldwide trend towards
the closure of institutions for people with mental illness. Coupled
with these closures, many government policies have focused on
reducing the number of hospital beds for peoplewith severemental
illness in favour of providing care in a variety of non-hospital
settings - outpatient clinics, day centres or community mental
health centres. These changes were consistent with the increasing
shift from hospital-based care in favour of a more community-
focused approach (Malone 2007).
Description of the condition
Worldwide, more than 25% of people develop one or more men-
tal or behavioural disorders, during their entire lifetime (WHO
2001). Schizophrenia is one such illness, heavily contributing to
the numbers of people considered severely mentally ill. The life-
time prevalence of schizophrenia alone is one per cent in the adult
population (Warner 1995). Currently schizophrenia is 26th on
the list of diseases ranked according to contribution to overall bur-
den in terms of disability-adjusted life years (DALYs). Its rank-
ing is projected to rise to 20th by the year 2020, with more than
17 million DALYs lost (accounting for 1.25% of overall burden)
(Murray 1996).
Description of the intervention
The psychiatric day hospital (or ’partial hospitalisation program’
as it is called in the USA) has been defined as “an ambulatory
treatment program that includes the major diagnostic, medical,
psychiatric, psychosocial, and pre-vocational treatment modali-
ties designed for people with serious mental disorders who require
co-ordinated, intensive, comprehensive, and multi-disciplinary
treatment not provided in an outpatient clinic setting” (Casarino
1982). The day hospital was originally developed as an alternative
to inpatient care (Cameron 1947) but it can also be used as an
alternative to outpatient care.
The term ’day treatment programme’ is usually applied to day
hospitals (Rosie 1987). The day hospital can bridge the gap be-
tween hospital and outpatient care for people who have just been
discharged from inpatient care. The term ’transitional day care’
is usually applied to day hospitals used in this way (Glick 1986).
’Day care centres’ are usually similar in their remit to that of day
hospitals but tend not to be run by hospitals or hospital staff. In
doing so theymay have a more social and less medical focus (Rosie
1987).
How the intervention might work
Day hospitalsmay afford a greater intensity of treatment and closer
engagement with services than that available through outpatient
care alone. It has been proposed that people with severe mental
illness might experience greater symptomatic improvement with
the more intensive input offered by the day hospital (Bateman
2000, Moscowitz 1980, Schene 1988) when compared with peo-
ple given outpatient care. Those with severe long-term disorders
might experience closer engagement (Lamb 1967), and hence im-
proved clinical outcome (Lamb 1967) and a reduced readmission
rate (Guidry 1979, Moscowitz 1980), when given access to the
structured support and a range of treatments offered by long-term
attendance at a day hospital. Alongside the above, other benefits
may include reduced cost of care and reduced duration of read-
mission.
Why it is important to do this review
Psychiatric day hospitals offer considerable care to large numbers
of people with severe mental illnesses. Proponents have claimed
that it can provide more cost-effective care by promoting quicker
recovery (Cameron 1947), improving social functioning (Greene
1981, Schene 1986), reducing family burden (Pang 1985), short-
ening the duration of hospital care (Parker 1990) and reducing
relapse rates (Moscowitz 1980). Critics of day treatment pro-
grammes, however, have argued that people who use them find
day treatment programmes “neither congenial nor especially help-
ful” (Anonymous 1987), that day hospitals ’institutionalise’ peo-
ple and fail to provide focused, effective treatment (Hoge 1992,
Pryce 1982, Tantam 1989) and highlight high rates of loss to
follow up in day hospital studies (Wilkinson 1984). This review
substantially updates the previous version of this Cochrane review
(Marshall 2001).
O B J E C T I V E S
To assess the effects of day hospital care as an alternative to con-
tinuing outpatient care for people with schizophrenia.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All relevant randomised controlled trials (RCTs). We did not in-
clude quasi-randomised studies, such as those allocating by using
alternate days of the week. If trials were described in some way
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as to suggest or imply that the study was randomised and the de-
mographic details of each group’s participants were similar, we in-
cluded these trials and undertook a sensitivity analysis on primary
outcomes to see if substantive differences resulted from inclusion
of these data.
Types of participants
People aged between 18-65 years, suffering from illness such as
schizophrenia, schizophrenia-like disorders and bipolar disorder.
Only those not acutely ill were included. Substance abuse was not
considered to be a severemental disorder in its own right.However
studies were eligible if they dealt with people with both diagnoses
- that is those with severe mental illness plus substance abuse. For
the purposes of this review dementia and learning disabilities were
not considered to be severe mental disorders.
Types of interventions
1. Day hospital: an ambulatory treatment program organised by
health care professionals that may include diagnostic, medical,
psychiatric, psychosocial and pre-vocational treatment modalities
designed for people with serious mental disorders who require co-
ordinated, intensive, comprehensive and multi-disciplinary treat-
ment not provided in an outpatient clinic setting (similar defini-
tion to Casarino 1982). For example, day hospital care may in-
clude individual psychoanalytic psychotherapy, group therapy, ex-
pressive therapy, community meetings, meeting with case admin-
istrator, medication review, education and support. Designations
of ’day centres’, ’day treatment centres’ and ’transitional day hos-
pitals’ tend to be used interchangeably and there is confusion in
this area. We suggest that day centres are mostly organised and
run outside of health services and do not have emphasis on med-
ication and diagnoses. Day treatment centres are more under the
auspices of health services and tend to focus not only on social
problems, employment etc. but also medical care of the people
attending - including use of medication. Finally ’transitional day
hospitals’ tend to be run by the health services but are used to help
the transition from ward to community or even vice versa. The
may be used to avoid admission as a compromise rather than full
admission as an inpatient.
2. Outpatient care: office-based practice which aims to provide
support and maintenance therapy for people with mental disor-
ders. This is usually conducted by one health care professional,
often a medical practitioner psychiatrist or specialised nurse. Care
involves symptom assessment, identification of adverse effects, ad-
justment of chemotherapy and perhaps social assistance. Each ap-
pointment is often less than thirty minutes and may be once every
week, but is more commonly once every few weeks or months.
Types of outcome measures
All outcomes were grouped by time into short term (up to 6
months), medium term (7 months to 12 months) and long term
(over 12 months). Where available, 24 months was the preferred
follow-up point for calculating mean days per months in hospital.
When more than one follow up point within the same period was
available we reported the latest one.
Primary outcomes
1. Service use
1.1 Hospitalisation: mean number of days per month in hospital
1.2 Not remaining in contact with psychiatric services
Secondary outcomes
1. Death - suicide and all causes
2. Service use
2.1 Hospitalisation: Admitted to hospital across time
2.2 Hospitalisation: Number of admissions across time
2.3 Use of services outside of mental health provision (i.e. emer-
gency services)
3. Global state
3.1 Leaving the study early (lost to follow up)
3.2 Relapse (as defined in trial)
3.3 Not improved to a clinically meaningful extent (as defined in
trial)
3.4 Not improved
3.5 Improvement - average endpoint score
3.6 Improvement - average change score
3.7 Compliance with medication
3.7.1 Compliance - average endpoint score
3.7.2 Compliance - average change score
4. Social functioning
4.1 Imprisonment (i.e. police contacts & arrests)
4.2 Employment status (number unemployed at end of study)
4.3 Accommodation status (number homeless or not living inde-
pendently during or at the end of the study, mean days homeless
and mean days in stable accommodation per month in study)
4.4 Alcohol use
4.5 Illicit drug use
4.5.1 Illicit drug use - average endpoint score
4.5.2 Illicit drug use - average change score
5. Mental state
5.1 General symptoms
5.1.1 Not improved to a clinically meaningful extent (as defined
in trial)
5.1.2 Not improved
5.1.3 Average endpoint score
5.1.4 Average change score
5.2 Specific symptoms
5.2.1 Positive symptoms (delusions, hallucinations, disordered
thinking)
5.2.1.1 Not improved to a clinically meaningful extent (as defined
in trial)
5.2.1.2 Not improved
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5.2.1.3 Average endpoint score
5.2.1.4 Average change score
5.2.2Negative symptoms (avolition, poor self-care, blunted affect)
5.2.2.1 Not improved to a clinically meaningful extent (as defined
in trial)
5.2.2.2 Not improved
5.2.2.3 Average endpoint score
5.2.2.4 Average change score
5.2.3 Mood depression
5.2.3.1 Not improved to a clinically meaningful extent (as defined
in trial)
5.2.3.2 Not improved
5.2.3.3 Average endpoint score
5.2.3.4 Average change score
6. Behaviour
6.1 General behaviour
6.1.1 Not improved to a clinically meaningful extent (as defined
in trial)
6.1.2 Not improved
6.1.3 Average endpoint score
6.1.4 Average change score
6.2 Specific behaviours (i.e. self-harm; injury to others or property)
7. Quality of life
7.1 Not improved to a clinically meaningful extent (as defined in
trial)
7.2 Not improved
7.3 Average endpoint score
7.4 Average change score
7.5 Patient satisfaction
7.5.1 Not improved to a clinically meaningful extent (as defined
in trial)
7.5.2 Not improved
7.5.3 Average endpoint score
7.5.4 Average change score
7.6 Carer satisfaction
7.6.1 Not improved to a clinically meaningful extent (as defined
in trial)
7.6.2 Not improved
7.6.3 Average endpoint score
7.6.4 Average change score
8. Economic
8.1 Costs of psychiatric hospital care
8.2 Costs of health care (including all medical and psychiatric care
and the costs of case management but excluding accommodation
other than hospital care)
8.3 Costs of all care (including costs of accommodation and sub-
tracting benefits (such as earnings) where these are known)
Search methods for identification of studies
1. We searched the Cochrane Schizophrenia Group Trials Register
(May 2009). This register is compiled by systematic searches ofma-
jor databases like CINAHL, EMBASE, MEDLINE, PsycINFO
as well as hand searches and conference proceedings (see Group
Module).
2. For search methods of earlier versions of this review (Marshall
2001) please see appendix (Appendix 1).
Electronic searches
The Cochrane Schizophrenia Group Trials Register (May 2009)
was searched using the phrase:
(*transitional*OR*posthospital*OR*partial hospitali?ation*OR
*daily living programme* OR *Ambulatory treatment* OR *pa-
tient care team*OR *communitymental health*OR *patient par-
ticipation* OR *drop-in hospital* OR *drop-in care* OR *drop-
in treatment* OR *drop-in cent* OR *drop-in unit* OR *drop in
hospital* OR *drop in care* OR *drop in treatment* OR *drop
in cent* OR *drop in unit* OR *day hospital* OR *day care* OR
*day treatment* OR *day cent* OR *day unit* OR *care program
approach* OR *care programme* in title, abstract, index terms of
REFERENCE and in interventions of STUDY) OR (*Pact* OR
*tcl* In title) OR (Pact* OR tcl* in abstract and index terms of
REFERENCE and in interventions of STUDY)
Searching other resources
1. References
Should an included or excluded study suggest that another study
was of relevance, the reference was identified and the full text
acquired.
2. Personal contact
Where required for additional data we contacted authors of trials
for this information. We did not systematically contact all authors
for additional papers. We contacted relevant pharmaceutical com-
panies and drug approval agencies for additional information.
Data collection and analysis
Selection of studies
The principal review author (ES) inspected all abstracts of stud-
ies identified as above and identified potentially relevant reports.
In addition, to ensure reliability, authors AS and FS inspected a
random sample of these abstracts, comprising 10% of the total.
Where disagreement occurred this was resolved by discussion, or
where there was still doubt, the full article was acquired for further
inspection. The full articles of relevant reports were acquired for
reassessment and carefully inspected for a final decision on inclu-
sion (see Criteria for considering studies for this review). Once the
full articles were obtained, authors ES, AS and FS inspected all full
reports and independently decided whether they met inclusion
criteria. Authors ES, AS and FS were not blinded to the names
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of the authors, institutions or journal of publication. Where dif-
ficulties or disputes arose, we asked Clive Adams (Co-ordinating
editor of the Cochrane Schizophrenia Group) for help and if it was
impossible to decide, these studies were added to those awaiting
assessment and the authors of the papers contacted for clarifica-
tion.
Data extraction and management
1. Extraction
1.1 Data regarding criteria and outcomes
Authors ES, AS and FS independently extracted data from in-
cluded studies. Again, any disagreement was discussed, decisions
documented and, if necessary, authors of studieswere contacted for
clarification. With remaining problems Clive Adams again helped
clarify issues and those final decisions were documented. Data pre-
sented only in graphs and figures were extracted whenever pos-
sible, but were included only if all review authors independently
came to the same results. Attempts were made to contact authors
through an open-ended request in order to obtain missing infor-
mation or for clarification whenever necessary.Where possible, we
extracted data relevant to each component centre of multi-centre
studies separately.
2. Management
2.1 Forms
Data were extracted onto standard, simple forms.
3. Scale-derived data
We included continuous data from rating scales only if:
a) the psychometric properties of the measuring instrument had
been described in a peer-reviewed journal (Marshall 2000); and
b) the measuring instrument was not written or modified by one
of the trialists for that particular trial; and
c) the measuring instrument was either (i) a self-report or (ii)
completed by an independent rater or relative (not the therapist).
4. Endpoint versus change data
We preferred to use scale endpoint data, which typically cannot
have negative values and is easier to interpret from a clinical point
of view. Change data are often not ordinal and are very problematic
to interpret. If endpoint data were unavailable we used change
data.
5. Skewed data
Continuous data on clinical and social outcomes are often not nor-
mally distributed. To avoid the pitfall of applying parametric tests
to non-parametric data, we aimed to apply the following standards
to all data before inclusion: a) standard deviations and means are
reported in the paper or obtainable from the authors; b) when a
scale starts from the finite number zero, the standard deviation,
when multiplied by two, is less than the mean (as otherwise the
mean is unlikely to be an appropriate measure of the centre of
the distribution, (Altman 1996); c) if a scale starts from a positive
value (such as PANSS which can have values from 30 to 210) the
calculation described above will be modified to take the scale start-
ing point into account. In these cases skew is present if 2SD>(S-
S min), where S is the mean score and S min is the minimum
score. Endpoint scores on scales often have a finite start and end
point and these rules can be applied. When continuous data are
presented on a scale which includes a possibility of negative values
(such as change data), it is difficult to tell whether data are skewed
or not. Skewed data from studies of less than 200 participants were
entered in additional tables rather than into an analysis. Skewed
data pose less of a problem when looking at means if the sample
size is large and were entered into syntheses.
6. Common measure
To facilitate comparison between trials, we intended to convert
variables that can be reported in different metrics, such as days in
hospital (mean days per year, per week or permonth) to a common
metric (e.g. mean days per month).
7. Conversion of continuous to binary
Where possible, efforts were made to convert outcome measures
to dichotomous data. This could be done by identifying cut-off
points on rating scales and dividing participants accordingly into
’clinically improved’ or ’not clinically improved’. It was generally
assumed that if there had been a 50% reduction in a scale-derived
score such as the Brief Psychiatric Rating Scale (BPRS, Overall
1962) or the Positive and Negative Syndrome Scale (PANSS, Kay
1986), this could be considered as a clinically significant response
( Leucht 2005a, Leucht 2005b). If data based on these thresholds
were not available, we used the primary cut-off presented by the
original authors.
8. Direction of graphs
Where possible, we entered data in such a way that the area to the
left of the line of no effect indicates a favourable outcome for day
hospital.
9. Summary of findings table
We anticipate including the following long-term main outcomes
in a summary of Findings table.
1. Service use
1.1 Hospitalisation: mean number of days per month in hospital
1.2 Hospital admission across time
2. Death - suicide
3. Global state
3.1 Leaving the study early (lost to follow up)
3.2 Relapse
4. Social functioning
4.1 Employment - unemployed at end of study
5. Mental state: general symptoms
5.1. Not improved to a clinically meaningful extent (as defined in
trial)
Within the Summary of findings table we assumed for calculation
of the low risk groups that the lowest control risk applied to all data.
We did the same for the assumption of the highest risk groups.
Assessment of risk of bias in included studies
Again working independently, authors ES, AS and FS assessed risk
of bias using the tool described in the Cochrane Handbook for
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Systematic Reviews of Interventions (Higgins 2008). This tool
encourages consideration of how the sequence was generated, how
allocation was concealed, the integrity of blinding at outcome, the
completeness of outcomedata, selective reporting andother biases.
We would have excluded studies where allocation was clearly not
concealed.
Trials with high risk of bias (defined as at least three out of five do-
mains categorized as ’No’) were removed from the ’included’ cate-
gory.. If the raters disagreed, the final rating was made by consen-
sus with the involvement of another member of the review group.
Where inadequate details of randomisation and other characteris-
tics of trials are provided, authors of the studies were contacted in
order to obtain further information. Non-concurrence in quality
assessment was reported.
Measures of treatment effect
1. Binary data
For binary outcomes we calculated a standard estimation of the
fixed-effects risk ratio (RR) and its 95% confidence interval (CI).
It has been shown that RR is more intuitive (Boissel 1999) than
odds ratios and that odds ratios tend to be interpreted as RR
by clinicians (Deeks 2000). For statistically significant results we
calculated the number needed to treat to provide benefit /to induce
harm statistic (NNTB/H) and its 95% confidence interval (CI)
using Visual Rx (http://www.nntonline.net/) taking account of
the event rate in the control group.
2. Continuous data
2.1 Summary statistic
For continuous outcomes we estimated a fixed-effect mean differ-
ence (MD) between groups. We preferred not to calculate effect
size measures (standardised mean difference (SMD)). However,
where scales were of such similarity to allow presuming there was
a small difference in measurement, we calculated it and, whenever
possible, we transformed the effect back to the units of one or
more of the specific instruments.
Unit of analysis issues
1. Cluster trials
Studies increasingly employ ’cluster randomisation’ (such as ran-
domisation by clinician or practice) but analysis and pooling of
clustered data poses problems. Firstly, authors often fail to account
for intraclass correlation in clustered studies, leading to a ’unit
of analysis’ error (Divine 1992) whereby p values are spuriously
low, confidence intervals unduly narrow and statistical significance
overestimated. This can cause type I errors (Bland 1997, Gulliford
1999).
Where clustering is not accounted for in primary studies, we pre-
sented data in a table, with a (*) symbol to indicate the presence
of a probable unit of analysis error. In subsequent versions of this
review we will seek to contact first authors of studies to obtain intr-
aclass correlation coefficients for their clustered data and to adjust
for this by using accepted methods (Gulliford 1999). Where clus-
tering had been incorporated into the analysis of primary studies,
we present these data as if from a non-cluster randomised study,
but adjusted for the clustering effect.
We have sought statistical advice and have been advised that the
binary data as presented in a report should be divided by a ’design
effect’. This is calculated using the mean number of participants
per cluster (m) and the intraclass correlation coefficient (ICC)
[Design effect = 1+(m-1)*ICC] (Donner 2002). If the ICC was
not reported it was assumed to be 0.1 (Ukoumunne 1999).
If cluster studies has been appropriately analysed taking into ac-
count intraclass correlation coefficients and relevant data docu-
mented in the report, synthesis with other studies would have been
possible using the generic inverse variance technique.
2. Cross-over trials
A major concern of cross-over trials is the carry-over effect. It oc-
curs if an effect (e.g. pharmacological, physiological or psycho-
logical) of the treatment in the first phase is carried over to the
second phase. As a consequence on entry to the second phase the
participants can differ systematically from their initial state despite
a wash-out phase. For the same reason cross-over trials are not ap-
propriate if the condition of interest is unstable (Elbourne 2002).
As both effects are very likely in severe mental illness, we will only
use data of the first phase of cross-over studies.
3. Studies with multiple treatment groups
Where a study involved more than two treatment arms, if rele-
vant, the additional treatment arms were presented in compar-
isons. Where the additional treatment arms were not relevant,
these data were not reproduced.
Dealing with missing data
1. Overall loss of credibility
At some degree of loss of follow-up data must lose credibility (Xia
2007). For any particular outcome should more than 50% of data
be unaccounted for, we did not reproduce these data or use them
within analyses. If, however,more than 50% of those in one arm of
a study were lost, but the total loss was less than 50%, we marked
such data with (*) to indicate that such a result may well be prone
to bias.
2. Binary
In the case where attrition for a binary outcome is between 0 and
50% and where these data were not clearly described, data were
presented on a ’once-randomised-always-analyse’ basis (an inten-
tion-to-treat analysis). Those lost to follow up were all assumed to
have the same rates of negative outcome as those who completed,
with the exception of the outcome of death. A sensitivity analysis
was undertaken testing how prone the primary outcomes were to
change when ’completed’ data only were compared to the inten-
tion-to-treat analysis using the above assumption.
3. Continuous
3.1 Attrition
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In the case where attrition for a continuous outcome is between 0
and 50% and completer-only data were reported, we have repro-
duced these.
3.2 Standard deviations
3.2.1 General
Where there are missing measures of variance for continuous data
but an exact standard error and confidence interval are available for
groupmeans , either ‘p’ value or ’t’ value are available for differences
in mean, we will calculate standard deviation value according to
methods described in Section7.7.3 of theCochraneHandbook for
Systematic Reviews of Interventions (Higgins 2008). If standard
deviations were not reported and could not be calculated from
available data, we asked authors to supply the data. In the absence
of data from authors, we used the mean standard deviation from
other studies.
3.2.2 Standard deviation mean number of days per month in hos-
pital
For the primary outcome, mean number of days per month in
hospital, if standard deviations were not reported and could not
be calculated from available data, we asked authors for additional
information. In the absence of data from authors, we calculated
missing standard deviations using a regression analysis of standard
deviation against mean, based on data from studies which did
report these data.
3.3 Last observation carried forward
We anticipated that in some studies themethod of last observation
carried forward (LOCF) would be employed within the study
report. As with all methods of imputation to deal with missing
data, LOCF introduces uncertainty about the reliability of the
results. Therefore, where LOCF data has been used in the trial, if
less than 50% of the data had been assumed, we reproduced these
data and indicated that they are the product of LOCFassumptions.
Assessment of heterogeneity
1. Clinical heterogeneity
We considered all included studies initially, without seeing com-
parison data, to judge clinical heterogeneity. We simply inspected
all studies for clearly outlying situations or people which we had
not predicted would arise. Should such situations or participant
groups have arisen they were fully discussed.
2. Methodological heterogeneity
We considered all included studies initially, without seeing com-
parison data, to judge methodological heterogeneity. We simply
inspected all studies for clearly outlying methods which we had
not predicted would arise. Should such methodological outliers
have arisen they were fully discussed.
3. Statistical
3.1 Visual inspection
We visually inspected graphs to investigate the possibility of sta-
tistical heterogeneity.
3.2 Employing the I2statistic
Heterogeneity between studies was investigated by considering
the I2 method alongside the Chi2 ’p’ value. The I2 provides an
estimate of the percentage of inconsistency thought to be due to
chance (Higgins 2003). The importance of the observed value of I
2 depends on i. magnitude and direction of effects and ii. strength
of evidence for heterogeneity (e.g. ’p’ value from Chi2 test, or a
confidence interval for I2).
I2 estimate greater than or equal to 50% accompanied by a sta-
tistically significant Chi2 statistic, was interpreted as evidence of
substantial levels of heterogeneity (Section 9.5.2 - Higgins 2008)
and reasons for heterogeneity were explored. If the inconsistency
was high and the clear reasons were found, data were presented
separately.
Assessment of reporting biases
Reporting biases arise when the dissemination of research findings
is influenced by the nature and direction of results (Egger 1997).
These are described in Section 10 of the Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2008). We are
aware that funnel plots may be useful in investigating reporting
biases but are of limited power to detect small-study effects. We
did not use funnel plots for outcomes where there were ten or
fewer studies, or where all studies were of similar sizes. In other
cases, where funnel plots were possible, we sought statistical advice
in their interpretation.
Data synthesis
Where possible we employed a fixed-effect model for analyses.
We understand that there is no closed argument for preference
for use of fixed or random-effects models. The random-effects
method incorporates an assumption that the different studies are
estimating different, yet related, intervention effects. This does
seem true to us, however, random-effects does put added weight
onto the smaller of the studies - those trials that aremost vulnerable
to bias. It is for this reason we use the assumption-free fixed-effect
model.
Subgroup analysis and investigation of heterogeneity
1. Subgroup analyses
We anticipated no sub-group analyses.
2. Investigation of heterogeneity
2.1 Unanticipated heterogeneity
Should unanticipated clinical or methodological heterogeneity be
obvious we will simply state hypotheses regarding these for future
reviews or versions of this review.Wedonot anticipate undertaking
analyses relating to these.
2.2 Anticipated heterogeneity
We did not anticipate any heterogeneity.
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Sensitivity analysis
1. Implication of randomisation
We aimed to include trials in a sensitivity analysis if they are de-
scribed in some way as to imply randomisation. For the primary
outcomes we included these studies and if there was no substan-
tive difference when the implied randomised studies were added
to those with better description of randomisation, then all data
were employed from these studies.
2. Assumptions for lost binary data
Where assumptions had to bemade regarding people lost to follow
up (see Dealing with missing data) we compared the findings of
the primary outcomes when we used our assumption compared
with completer data only. If there was a substantial difference, we
reported results and discuss them but continued to employ our
assumption.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of studies awaiting classification.
Results of the search
1. Original search - 2001
The first version of this review (Marshall 2001) undertook a large
search. The search was done by deriving a list of search terms
from reading overviews of the field and consulting experts in day
hospital care. The reference databases listed in Appendix 1 were
searched.
2. Update search - 2009
The May 2009 update search of the Cochrane Schizophrenia
Group’s Register of Trials yielded 1104 references (from 565 stud-
ies). Initial screening reduced this figure to 28 references. After
additional evaluation, 12 trials were selected for further inspection
and full texts of articles were ordered.
Included studies
For substantive descriptions of studies please see Characteristics of
included studies tables.
The original review,Marshall 2001, included eight trials.However,
four of these did not meet the entry criteria for the present review
(Bateman 1999, Dick 1985, Piper 1993, Tyrer 1979). Although
all studies were randomised controlled trials, only four had data
specifically about people with schizophrenia (Glick 1986, Linn
1979, Meltzoff 1966, Weldon 1979). Additional references from
the search results have not contributed to the included studies.
Thus the present review includes four studies.
1. Length of trials
The trials had follow up periods of three months (Weldon 1979),
12 months (Glick 1986), 18 months (Meltzoff 1966), and 24
months (Linn 1979). Three months would appear to be a short
follow up period given that day care centres are directed at im-
proving outcome in the long term for severely mentally ill people.
2. Setting
All studies were undertaken in the USA. Weldon 1979 and Glick
1986 were from the Payne Whitney Clinic of New York Hospital.
The earlier study involved working with only people referred from
inpatient wards and the latter from both in- and outpatient care.
Meltzoff 1966 and Linn 1979 were both set within the Veterans
Administration system of health care. Linn 1979 was multicentre
with 10 hospitals taking place (California - two, Texas - three,
Illinois - one, Florida - one, Iowa - one,Minnesota - one, Tennessee
- one).
3. Participants
Linn 1979 recruited people with schizophrenia who had just been
discharged from inpatient care. This trial was conducted in Veter-
ans’ Administration hospitals and was restricted to men only. The
diagnosis of schizophrenia was confirmed by a psychiatrist using
unspecified criteria. Meltzoff 1966 was also a Veterans’ Admin-
istration trial. This trial recruited men “with a neuropsychiatric
disability” who had spent time in hospital, and were not suici-
dal or violent. Ninety-one per cent had schizophrenia, though it
was unclear how this diagnosis was made. Weldon 1979 recruited
people with schizophrenia who had recently been discharged from
inpatient care and had no history of self-harm, violent behaviour
or drug abuse. It was unclear how the diagnosis of schizophrenia
was made. In contrast to the other two trials, the majority of par-
ticipants were women (21 out of 30). Glick 1986 recruited people
with schizophrenia or major affective disorders who were referred
from the inpatient wards of a large psychiatric hospital. Partici-
pants were required to have residual psychotic symptoms and a
need for ongoing treatment.
3. Study size
No study reported a pre-trial power calculation. The trials in de-
scending order of size were: Linn 1979 (n=162), Glick 1986 (n=
79), Meltzoff 1966 (n=80) and Weldon 1979 (n=30).
4. Interventions
4.1 Day hospital
We think that Linn 1979, Meltzoff 1966 and Weldon 1979 fall
into the same broad category of ’day treatment centres’. In Linn
1979 there were 10 Veterans’ Administration day care centres that
aimed to enhance social functioning for the long term by offering
a place to socialise and engage in productive activities. The centres
employed social workers and physicians and offered: recreational
activities, group therapy, counselling, occupational therapy and
medication follow up. For Meltzoff 1966 the day care centre of-
fered individual and group psychotherapy and medication. The
staff to patient ratio was not reported. In Weldon 1979 the day
care centre group received group therapy, medication and struc-
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tured activities. The staff to patient ratio was 1:2.5.
In Glick 1986, however, the day hospital aimed to enhance social
functioning in chronic patients by offering a place to socialise
and engage in productive activities. The hospital employed social
workers and physicians and offered: recreational activities, group
therapy, counselling, occupational therapy, and medication follow
up. Staff members acted as a case managers, managed one-to-
one intervention and coordinated patients care plans. Existing
inpatient staff were used to provide daily recreational therapy/
weekly dance therapy. Inpatient medical staff provided ongoing
medical management. The “transitional treatment staff ” were also
part of inpatient unit staff and were therefore familiar with all
patients before their initiation into program. We feel justified in
categorising this differently to the other three trials and calling it
a ’transitional day hospital’.
4.2 Outpatient care
Control treatments for each study were as follows: Linn 1979 and
Glick 1986 provided outpatient drug management from the same
physicians as worked in the day care centres, no other aftercare was
offered. InMeltzoff 1966 participants received standard outpatient
care and in Weldon 1979 participants received psychotherapy-
oriented outpatient care, but also offered medication.
5. Outcomes
5.1 General remarks
Data were available for the outcomes of service use (admitted to
hospital), global state (lost to follow up), social functioning (em-
ployment) and death. The outcomes of admitted to hospital and
lost to follow up had been pre-stipulated as the primary outcomes
of this review.
5.2 Outcome scales
Details of the scales that supplied usable data for this review are
shown below. Reasons for exclusion of data from other scales are
given under ’Outcomes’ in the ’Characteristics of included studies
5.2.1 Global functioning
5.2.1.1 Global Assessment scale (GAS) (Endicott 1976)
This interviewer-rated scale is used to make a global assessment
of the severity of psychiatric disturbance. Higher scores indicate
better functioning.
5.2.2 Mental state
5.2.2.1 Brief Psychiatric Rating Scale (BPRS) (Overall 1962)
This interviewer-rated scale assesses the severity of psychiatric
symptoms. The original scale has 16 items, but a revised 18-item
scale is commonly used. Each item is defined on a seven-point
scale from ’not present’ to ’extremely severe’, scoring from zero to
six or one to seven. Scores can range from 0 to 126, with high
scores indicating more severe symptoms.
5.2.2.2 Psychiatric Evaluation Form (PSE) (Endicott 1972)
This interviewer-rated scale is used to evaluate the severity of psy-
chiatric symptoms. Higher scores indicate more severe symptoms.
5.2.2.3 Symptom Check List (SCL-90) (Derogatis 1977)
This self-report symptom inventory consists of 90 items for the
measurement of psychopathology in psychiatric and medical pa-
tients (in its earliest form it was the 59-item Hopkins Symptom
Checklist). Participants are asked to rate distress due to particular
symptoms on a five point scale from one (not at all) to five (ex-
treme) over the previous 14 days.
5.2.3 Social functioning
5.2.3.1 Community Adaption Scale (CAS) (Roen 1966)
This interviewer-rated scale assesses social functioning. Higher
scores indicate lower functioning.
5.2.3.2 SAS (Weissman 1981)
This interviewer-rated scale assesses social functioning. Higher
scores indicate poorer social functioning.
5.2.3.3 Social Dysfunction Rating Scale (SDRS) (Linn 1969)
This interviewer-rated scale consists of 21 items assessing social
functioning. Each item is rated on a six-point scale with higher
scores indicating poorer social functioning.
5.3 Missing outcomes
No usable data were available for quality of life, adverse events,
burden on relatives, mean monthly cost of all care and satisfaction
with care.
Excluded studies
For substantive descriptions of studies please see Characteristics of
excluded studies tables.
Sixty-five studies were excluded in the original review (Marshall
2001), 43 were non-randomised studies and 22 were randomised
but not of relevance. The non-randomised studies consisted of:
two surveys (without comparison groups), 11 surveys with com-
parison groups, two uncontrolled follow up studies, four ’before
and after’ comparisons, eight case-control or retrospective cohort
studies, and 16 quasi-experimental designs (i.e. comparative tri-
als without randomisation). The excluded randomised controlled
trials consisted of: one trial of admission to hospital versus outpa-
tient care, 11 trials of acute day hospital care versus admission, five
trials of day hospital care (to reduce duration of admission) versus
admission, four trials of enhanced day hospital care (enhanced by
cognitive therapy, problem solving, group therapy and self-control
therapy respectively) versus standard day hospital care, and one
trial that could not be classified (Guy 1969) as the day hospital
in question functioned simultaneously as a day care centre, day
treatment programme and transitional day hospital. We looked at
this study in the light of this updated version. We excluded this
study as participants were “in need of inpatient care” and can not
be ascertained as “not acutely ill”.
The original review (Marshall 2001) included eight studies which
were all re-evaluated for the present update.Out of these four stud-
ies had to be excluded as their focus was on people with depres-
sion, anxiety, personality disorder, neurotic disorders and not peo-
ple with schizophrenia (Bateman 1999, Dick 1991, Piper 1993,
Tyrer 1979).
Seven trials, which had been on awaiting assessment list in the
earlier version of this review were also evaluated. Five studies had
to be excluded as being non-randomised trials (Bertrand 1973,
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McDonnell 1977, Newton 1983, Prior 1998, Vietze 1976), one
randomised control trial (Skoda 1983) was excluded as a study
for people with neuroses not schizophrenia and one study (Pang
1985) used inpatients as a control group, not day hospital versus
outpatient care.
The Priebe-MECCA-2002 randomised controlled trial, ongoing
at the time of the earlier version of this review, was excluded as
it was a package of care within which outcomes were fed back to
patients and was not day hospital versus outpatient care. Priebe
2006 is a randomised trial testing day hospital versus inpatient care
and Priebe 1999 is a randomised trial testing treatment changes
according to patient wishes, not day hospital versus outpatient
care. Another randomised controlled trial (Reynolds 2004) was
excluded as a trial testing transitional discharge model versus re-
ferral to locally-based nurses, not the day hospital versus outpa-
tient care and finally Takano 1995 and Tsukahara 1998 were not
randomised.
In total eighty-seven studies were evaluated and eighty-two were
excluded in the present review.
Awaiting assessment
After extensive searching only one study, Dal Santo 2004, remains
on the awaiting assessment list, the full text of the article continues
to be sought.
Ongoing studies
As far as we know there are no ongoing studies of relevance.
Risk of bias in included studies
For multi-centre trials providing data for single centres, we did not
assess the risk of bias for each centre. Our judgments regarding the
overall risk of bias in individual studies are illustrated in Figure 1.
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Figure 1. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
Allocation
Four studies were stated to be randomised but only Meltzoff 1966
provided descriptions of the methods used to generate the se-
quencewith 80 cards shuffledby use of randomnumber. The other
studies, Linn 1979, Weldon 1979, and Glick 1986, therefore, are
classified as of ’unclear’ quality with a moderate risk of selection
bias and of overestimate of positive effect as no description of the
methods used to generate the sequence had been provided.
Regarding allocation concealment, only two trials provided de-
scription of allocation concealment. Linn 1979 randomised by
sealed envelope and Meltzoff 1966 by a random numbers table.
Data from Weldon 1979 and Glick 1986 did not specify the
method of concealment and, therefore, may be subject to bias. It is
known that poor reporting of randomisation increases the chances
of ’significant’ outcomes (Schulz 1995).
Blinding
We classified blinding in respect only to primary outcomes. Due
to the nature of the interventions (day hospital versus outpatient
care), we assumed participants and clinicians were not blind to
treatment assignment. We also assumed that primary outcomes
were likely to be influenced by participant and clinician’s lack of
blinding, as the knowledge of treatment allocation could deter-
mine both performance and attrition bias at a level which is dif-
ficult to predict/quantify. We did not, however, consider the pri-
mary outcomes as interviewer mediated, so we assume that lack of
interviewer blinding would produce less detection bias. Therefore
all studies providing primary outcome data are classified as of ‘un-
clear’ quality with a moderate risk of performance and attrition
bias. This gathers further potential for overestimate of positive ef-
fects and underestimate of negative ones.
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We report blinding to secondary outcomes in the risk of bias table
but we do not account for it in the global rating of studies’ risk
of bias. Again, if a secondary outcome was clinician/participant
mediated, we rated it as ‘unclear’. If it was interviewer rated, we
assessed it according to information provided in the study.
In Linn 1979 there were professional, independent, raters. Study
authors affirm that collection of outcome data was indeed blinded.
Weldon 1979 andGlick 1986 were not blinded by design, whereas
in Meltzoff 1966 it was unclear whether blinding was successful
even when authors stated that research personnel had no dealing
with patients.
Incomplete outcome data
Follow up rates were as follows: Weldon 1979 100% at three
months, Glick 1986 67% at 12 months, Meltzoff 1966 86.3% at
18 months and Linn 1979 85% at 24 months. Weldon 1979 was
judged as low risk of attrition bias because there was no loss to
follow up in this study.
Glick 1986, Linn 1979, and Meltzoff 1966 were rated as ‘unclear’
with a moderate risk of attrition bias. They either did not address
this issue (Glick 1986 - the reasons for leaving the study are not
mentioned) or presented insufficient information (Linn 1979 -
major reason for leaving the study was moving from area but data
was not reported by group allocation, Meltzoff 1966 - missing
data on 29 interviews reported but not explained) of attrition/
exclusions to permit judgment.
Selective reporting
We have no trial protocols. In the published papers the methods
described are consistent with outcomes reported. One trial failed
to collect outcome data that could be analysed on an intention-
to-treat basis. Meltzoff 1966 excluded people after randomisation,
who had either failed to engage in treatment or were in hospital at
the time of follow up. All studies were rated as of ‘unclear’ quality
with a moderate risk of selective reporting.
Other potential sources of bias
Although, we found no obvious evidence of other bias occurring
and all trials were publicly funded, we rated as ‘unclear’ our judg-
ment for other potential sources of bias. No declaration of interest
was made by authors, and we assumed there was none to be made.
However, some study authors were active supporters of the day
hospital care model across the scientific community and clinical
world. This raises the issue on how researcher beliefs could affect
the entire process of evaluating an intervention in a randomised
clinical trial. Although conscious of this issue, we decided not to
make any attempt in rating it as it is very difficult to judge and
erroneous quantification could drive bias into our conclusions.
Effects of interventions
See: Summary of findings for the main comparison DAY
HOSPITAL versus OUT-PATIENT CARE for people with
schizophrenia near or on discharge
1. COMPARISON 1. DAY HOSPITAL versus OUTPATIENT
CARE - NEAR OR ON DISCHARGE
1.1 Primary outcomes
1.1.1 Service use
1.1.1.1 Hospitalisation: mean number of days per month in hos-
pital
Only Linn 1979 (n=162, day treatment centre) reported data for
this important outcome. This trial suggested that that people allo-
cated to day centres spent significantly fewer days in inpatient care
over a two-year period (day centre 77.9, n=80 vs outpatient 95.9,
n=82). These data are not, however, accompanied by p-value, vari-
ance or confidence intervals.
1.1.1.2 Not remaining in contact with psychiatric services
The nearest outcome to our second desired primary outcome was:
Global state - Leaving the study early (lost to follow up - day treat-
ment centres / transitional day hospital). We found no clear dif-
ference between day hospital and outpatient care for the outcome
of ‘lost to follow up’ (n=147, 3 RCTs, RR at 6 months 0.97 CI
0.48 to 1.95 ’moderate’ quality GRADE, Summary of findings for
the main comparison; n=117, 2 RCTs, RR at 12 months 0.97 CI
0.48 to 1.95, ’low’ quality GRADE, Summary of findings for the
main comparison).
1.2 Secondary outcomes
1.2.1 Death - suicide and all causes - day treatment centres
One small study (Weldon 1979, n=30) reported on mortality at
three months with no deaths in either group.
1.2.2 Service use
1.2.2.1 Admitted to hospital across time - day treatment centres
By six months about 20% of both groups had been admitted
(n=110, 2 RCTs, RR 0.58 CI 0.26 to 1.33, ’moderate’ quality
GRADE, Summary of findings for the main comparison). By the
one-year follow up this proportion increased but was slightly dif-
ferent between the two groups (n=242, 2 RCTs, RR 0.73 CI 0.54
to 1.00, ’low’ quality GRADE, Summary of findings for the main
comparison). After that period a clear difference in favour of day
hospital is apparent but these data are heterogeneous (n=242, 2
RCTs, RR0.71CI 0.56 to 0.89, I2 =74%P=0.05, ’moderate’ qual-
ity GRADE, Summary of findings for the main comparison) and,
according to our protocol should not be summated. We wanted to
display the findings all together and are unable to restrict synthesis
to the first two subgroups.
1.2.3 Global state
1.2.3.1 Number lost to follow up
We have reported this outcome, please see above 1.1.1.2 Service
use: Not remaining in contact with psychiatric services.
1.2.3.2 Average score (GAS, high score = good) - transitional day
hospital
All data originate from Glick 1986 (data from schizophrenia sub-
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group only). This study reports no difference between the two
interventions with (n=37, 1 RCT, MD by 6 months -7.9 CI -
15.68 to -0.12; MD by/at 12 months -4.31 CI -15.24 to 6.62).
1.2.4 Social functioning
1.2.4.1 Average scores (CAS - day treatment centres, SAS - tran-
sitional day hospital)
Weldon 1979 reported no significant difference in social func-
tioning as measured by Community Adaption Scale (CAS) by six
months (n=30, 1 RCT, MD -0.03 CI -0.30 to 0.24). Glick 1986
found a borderline significant difference at six months in favour
of the people allocated to outpatient care (n=37, 1 RCT,MD 0.36
CI -0.07 to 0.79) but even this difference in social functioning as
measured by SAS was lost by 12 months (n=37, 1 RCT, MD 0.17
CI -0.25 to 0.59). Linn 1979 (n=162) reported a significant time
by group difference on social functioning (SDRS) in favour of the
day centre group but univariate comparisons at 6, 12, 18 and 24
months were not significant. These data could not be added to
the meta-analysis, as numbers at each follow up point, standard
deviations, p-values and confidence intervals were not reported.
1.2.4.2 Unemployed - day treatment centres
At six months Weldon 1979 reported an effect favouring the
day hospital group (n=30, 1 RCT, RR 0.04 CI 0.00 to 0.62, P=
0.02, ’low’ quality GRADE, Summary of findings for the main
comparison), but by 12 months one other study, Meltzoff 1966,
found no difference between the day hospital and outpatient
groups (n=80, 1 RCT, RR unemployed 0.86 CI 0.69 to 1.06,
’moderate’ quality GRADE, Summary of findings for the main
comparison).
1.2.5 Mental state
1.2.5.1 Average scores (PEF - transitional day hospital, POMS,
SCL 90 - day treatment centres)
Weldon 1979 reported no significant difference in mental state
by six months using the Symptom Check List (SCL-90) (n=30,
1 RCT, MD 0.31 CI -0.20 to 0.82). This same study reported
data on Profile of Mood States (POMS) and found no difference
between day hospital and outpatient groups (n=30, 1 RCT, MD
16.93 CI -20.49 to 54.35). One other small trial found no sig-
nificant difference in mental state between treatment and control
groups by six months (n=37, 1 RCT, MD on PEF 0.52 CI -0.02
to 1.06) or by one year (n=37, 1 RCT, MD on PEF 0.15 CI -0.46
to 0.76).
Linn 1979 (n=162) reported a significant time by group interac-
tion (ANOVA) in favour of day centre participants (at six months
day centre mean 37.4 control 38.1; 12 months day centre 36.0,
control 36.6; 18 months day centre 35.4, control 36.3; 24 months
day centre 31.3, control 38.4). In point by point comparisons only
the final difference at 24 months was significant (p<0.01, F=8.08).
These data could not be added to the meta-analysis as numbers of
people at each follow up point and standard deviations were not
reported.
1.2.6 Economic
Weldon 1979 (n=30) and Meltzoff 1966 (n=80) did not report
any economic data.
1.2.6.1 Costs of psychiatric hospital care - day treatment centres
Linn 1979 (n=162) reported a 32.8% increase in mean monthly
cost of psychiatric care in the day centre group, but these were
based on the costs of inpatient and day treatment centre care only,
and did not include the costs of outpatient care (day centre $246,
outpatient $185). The difference was reported as not significant
but this finding was difficult to evaluate as no standard deviations
were presented.
1.2.6.2 Overall costs of running the programme
Linn 1979 (n=162, day treatment centres) reports that the over-
all average cost for two years per person is $5,895 (day hos-
pital) versus $4,437 (outpatient care). Glick 1986 (n=37, sub-
group, transitional day hospital) estimates costs for the whole pro-
gramme as considerably less expensive for the outpatient pro-
gramme ($10,000 annual cost) compared with the costs of run-
ning the day hospital ($100,000 annual cost).
D I S C U S S I O N
Summary of main results
1. Service use
1.1 Hospitalisation: mean number of days per month in hospital
Our primaryoutcomewas time inhospital. Linn 1979 (n=162, day
treatment centre) reported these data and suggested that people
allocated to day centres spent significantly fewer days in inpatient
care over a two-year period but data were impossible to present
in graphical form. We did also find some information in Meltzoff
1966 (n=80, day treatment centre) in which the author reports
the total amount of time spent in hospital by people allocated to
out patient care was 172.5 man-months in contrast to 102 man-
months for day treatment centre (X2=15.57, p< 0.001). They note
that the savings of 70.5man-months (or approximately 2200 days)
was accrued within eighteen months of the study period. Again
these data are intriguing and important but difficult to generalise
to modern times, not well enough reported to synthesise, are from
an analysis of only those who completed the study and finally from
a single small trial. The impression is, however, that day hospital
does reduce time in inpatient care.
1.2 Not remaining in contact with psychiatric services
For our second key outcome, we found no clear difference between
day hospital and outpatient care for the outcome of ‘lost to follow
up’ (n=147, 3 RCTs, RR at 6 months 0.97 CI 0.48 to 1.95; n=
117, 2 RCTs, RR at 12 months 0.97 CI 0.48 to 1.95). These data
are heterogeneous (I2=53%, P=0.14) but there is the impression
that the day care does not really effect attrition from services. Glick
1986, the transitional service, is combined with the other two day
treatment centres and may add to the heterogeneity as it does seem
to be less positive than the other two studies. The text of Glick
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1986 suggested that transitional day hospital care was superior to
out patient care in keeping people engaged in treatment. However,
their sub-analysis indicated that this effect wasmainly due to better
engagement of people with affective disorders, not schizophrenia.
1.3 Service use: Admitted to hospital across time - day treatment
centres
Results suggest that day hospital care reduces rate of inpatient
admissions. This finding becomes statistically significant at, and
beyond, 12 months. The data are somewhat heterogeneous at 12
months (I2=60%, P=0.11) but more clearly so beyond that period
(I2 =74% P=0.05). We do not see clear reasons for this, except
perhaps that the latter of the two studies was undertaken in a
time when community care was well into the process of being
implemented. Thirteen years earlier, at the time of the first study,
the control group may not have had the additional community
resources that one would hope would be available for people in
distress and that may have been available in the late 1970s.
2. Death - suicide and all causes - day treatment centres
OnlyWeldon 1979 (n=30) reported on mortality at three months
(no deaths in either group) and this outcome was not reported by
any of the other trials. For this rare outcome to be investigated in
any study the size of the trial would have to be considerable. We
have no evidence that day hospital care helps or harms in terms of
death.
3. Global state
We have reported one of the global state outcomes above - please
see 1.2 Service use. Not remaining in contact with psychiatric
services.
3.1 Global state: 2. Average score (GAS, high score = good) -
transitional day hospital
Only Glick 1986 (n=37, sub-group) reported an average score
for global state. By six months there was about an eight-point
decline for those allocated to day hospital and this just reached
conventional levels of statistical significance. By 12 months this
difference was only about four points and not significant. In any
event we are unclear of the validity and clinical meaning of these
data. We do not think that participants who provided these data
were all whowere originally randomised, and are unsure if these are
really continuous data (and not ordinal). Even if valid themeaning
of eight or four points difference is problematic to ascertain.
4. Social functioning
3.1 Average scores (CAS - day treatment centres, SAS - transitional
day hospital)
Social functioning was measured by two different trials using two
different scales. Data are not conclusive.
4.2 Unemployed - day treatment centres
At six months Weldon 1979 (n=30) reported an effect favouring
the day hospital group (RR 0.04 CI 0.00 to 0.62, P=0.02), but
by 12 months one other study (Meltzoff 1966, n=80), found no
difference between the day hospital and outpatient groups (RR
unemployed 0.86 CI 0.69 to 1.06).
Data from two small trials (total n=110) tended to suggest that this
risk of unemployment was reduced by day hospital care. Synthesis-
ing the two results is inadvisable (Tau² = 9.79, Chi² = 10.95, df = 1,
P = 0.0009, I² = 91%) but both trials do seem generally supportive
of the idea that day hospital care can help people be employed.
However, the trial with the most favourable result for day hospital
care was set up in such way that it provided vocational therapy,
including paid employment to participants whereas the control
out patient care package did not. The second trial (Meltzoff 1966,
n=80) did also find in favour of the day care (n=80, RR 0.86 CI
0.69 to 1.06) although not to a statically significant extent. This
is again, another area for additional research.
5. Mental state
5.1 Average scores (PEF - transitional day hospital, POMS, SCL
90 - day treatment centres)
Three different small trials reported on mental state using three
different scales. All findings suggest that there was no clear advan-
tage or disadvantage for use of either package of care.
6. Economic
Economic datawere few, reported in different ways and impossible
to bring up to date. There was the suggestion, however, that day
hospital care ismore expensive both to establish and to run.This, of
course, is offset by the suggested saving in inpatient care - but these
calculations were not reported in any study. We remain unclear if
day hospital care does save money.
Overall completeness and applicability of
evidence
It is always possible that we may have failed to identify some stud-
ies. However, we have tried to be comprehensive as possible in
our search strategy and thorough in our consideration of every-
thing identified. There were losses of data from the studies we have
identified. People did not have data recorded once they left the
study, some data were presented without variance and completer
only data were reported in several studies. Should these trials be
reporting today it is likely that a more complete data set would
be available. We have already alluded to the possibility that some
data are difficult to apply in the context of modern services. The
oldest trial was undertaken over four decades ago when the stan-
dard care for people receiving outpatient care may not have been
as it is today. This is, however, open to dispute as most people who
suffer from schizophrenia live in countries where the additional
resources beyond that standard care outpatient services may not be
sophisticated. We do feel that the results we are presenting should
be interpreted with caution but not that they are inapplicable.
Quality of the evidence
The quality of the four trials providing data was not optimal
(Figure 1). Sequence generation is often not made explicit, alloca-
tion concealment is unclear, blinding is probably impossible most
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of the time and we are not sure of whether incomplete outcome
data has been well-addressed or that the studies were truly free of
selective reporting. We are, of course, judging these pioneering tri-
als by standards of today. The reporting of methods was not great
but at least these trialists did attempt to undertake most difficult
trials for important questions. The quality of methods would leave
us needing to exercise caution but we do not feel that it should lead
us to dismiss the important findings this review points towards.
Potential biases in the review process
The search may have failed to identify trials and, as with most
electronic searches, is most likely to find studies from high-income
countries. The studies we identified are small and there is also the
potential for publication bias or small study biases creeping into
the review. We have no protocols for the studies in this review so
are not clear if the reports we have identified really report all data
or a selection of the total results. We have tried to be as objective
as possible selecting and extracting data, summarising them and
undertaking the syntheses and write up. We welcome comments
on biases we may have inadvertently introduced. We are not aware
of any prior beliefs that would have influenced our production of
this review.
Agreements and disagreements with other
studies or reviews
This review substantially updates and improves past work. It
does, however, largely agree with findings from previous versions
(Marshall 2001) but has, perhaps, put less emphasis on positive
findings. This is probably because of the new risk of bias table
function of this version of RevMan.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
1. For people with schizophrenia
Currently the data to support the idea that day hospital or outpa-
tient care helps avoid admission is not strong. There are, however,
weak suggestions, that after a protracted period, day hospital care
may help a person avoid coming into inpatient care. The person
with schizophrenia will have to balance the implications of attend-
ing the day hospital, and all that entails for the deferring hospi-
talisation. We have no data to report on satisfaction with care or
quality of life and what limited data there are on mental state and
social functioning are equivocal.
2. For clinicians
Day hospital may help people in ways that have not beenmeasured
in these studies. On the other hand, it is perfectly feasible that
attendance at such institutions could be restricting and stigmatis-
ing. The data in the studies reported in this review are really lim-
ited in helping support a blanket policy but have a suggestion that
there may be some avoidance of readmission after a period of time.
Clinicians intending to make use of day treatment programmes
need to consider how far the inconvenience is balanced by the
(somewhat weak) evidence for its effectiveness. In several countries
day hospitals have been partially superseded by case management
approaches and vocational rehabilitation programmes.
3. For policy makers
Policy makers need to consider how far the cost of providing day
hospital care can be justified. Data on cost is very poor and out
of date. Where day hospital facilities are being used to provide
day programmes, clinicians and policy makers should consider
whether these resources would be better deployed offering a treat-
ment of more proven effectiveness.
Implications for research
1. General
This review highlighted the need for the improvement of quality
of reporting research findings. The trials are old and all predate the
firstCONSORTstatement by at least a decade (Begg1996). If they
had been able to anticipate CONSORT we would have had more
data to use for this review. Certainly all new studies should closely
comply with the minimum standards of CONSORT (Altman
2001).
2. Specific
We think that this review has demonstrated that there has not been
enough basic research comparing day hospital care with outpatient
care and that more trials are justified. We suggest a design taking
good features from each of the studies we have scrutinized for this
review (Table 1). Future research in this area needs to: a) provide a
clear definition of ’treatment refractory outpatient’; b) define the
ingredients of a ’day hospital’; c) compare day hospitals against
clearly a described outpatient treatment; and d) carry out a careful
analysis of cost effectiveness. It would be desirable for future trials
in this area to be on a larger scale.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Glick 1986
Methods Allocation: random - no further details.
Blindness: unclear if evaluator was independent of treating clinician or blind to group
allocation and if statistical analysis performed blind.
Duration: 12 months.
Setting: day hospital attached to New York Hospital.
Participants Diagnosis: schizophrenia n=37, major affective disorder n=42.
N=79 (sub-group of 37 reported in this review).
Age: ~30 years old (schizophrenia sub-group).
Sex: 22 M, 15 F (schizophrenia sub-group).
History: referred from inpatient wards of New York Hospital, number of previous ad-
missions not reported, had schizophrenia/major affective disorder; were discharged from
IP unit; 18 to 60; no more than two previous admissions; inadequate family support;
residual psychotic symptoms; need for ongoing treatment
Interventions 1. Transitional day care: about 15 hrs/wk, limited to 6 to 12 weeks, involving: milieu,
family, supportive & group therapy; medication; care management; recreation & dance
therapy; discharge planning. N=19.
2. OP follow-up: 6 to12 weeks in outpatient group therapy (90 mins/wk); medication
management; 24 hr crisis intervention. N=18
Outcomes Service use: hospital admission.
Global state: number lost to follow up, GAS
Social functioning: SAS.
Mental state: Psychiatric Evaluation Form.
Unable to use -
Service use: rate of admission (not reported by sub-groups).
Social functioning: Role performance Treatment Scale (unpublished scale).
Medication compliance (unpublished scale).
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear “randomly assigned” - subcategorised by di-
agnosis, no further details
Allocation concealment? Unclear No details.
Blinding?
All outcomes
No Not blinded by design.
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Glick 1986 (Continued)
Incomplete outcome data addressed?
All outcomes
Unclear The reasons for leaving the study are not
mentioned.
Free of selective reporting? Unclear Methods described consistent with out-
comes reported, no protocol available
Free of other bias? Unclear Authors did not declare sources of support
and the interests in study
Linn 1979
Methods Allocation: randomised.
Blindness: evaluator was independent of DTC and blind to allocation.
Duration: 24 months.
Setting: 10 Veterans’ Administration hospitals with associated Day Care centres
Participants Diagnosis: schizophrenia.
N=162 (N assessed = 175).
Age: average ~ 37 years old.
Sex: all male.
History: recently discharged from IP (158 days/year in hospital), referred for DH, av-
erage number of admissions in year preceding trial - 4.4, receiving maintenance level of
antipsychotic drugs, able to attend DH
Interventions 1. VA day care centre: employed social workers & physicians - aimed to enhance social
functioning by offering place to socialise and engage in productive activities, recreational
activities, group therapy, counselling, occupational therapy, medication follow up. N=
80.
2. OP drug management: same physicians as above - no other aftercare offered. N=82
Outcomes Service use: admission to hospital.
Unable to use -
Service use: mean days in hospital (no SD)
Global state: leaving the study early (not reported by group - 15% at 24 months).
Social functioning: SDRS (no SD).
Mental state: BPRS (no SD).
Cost of care (averages, no SD).
Attitudes (unpublished scale).
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Randomised - no further details.
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Linn 1979 (Continued)
Allocation concealment? Yes Bymeans of sealed envelope corresponding
to patient’s number
Blinding?
All outcomes
Yes Independent raters, authors affirm that
outcome data blinded
Incomplete outcome data addressed?
All outcomes
Unclear Major reason for leaving the study was
moving from area but not reported by
group of allocation
Free of selective reporting? Unclear Methods described consistent with out-
comes reported, no protocol available
Free of other bias? Unclear It was not reported whether blinding was
successful. Authors did not declare sources
of support and interests in the study
Meltzoff 1966
Methods Allocation: randomised.
Blindness: independent of treating clinicians, initially blind to group allocation. Unclear
if data analysis was carried out blind.
Duration: 18 months.
Setting: day care centre in New York.
Participants Diagnosis: 91% schizophrenia, 1.5 % affective, 6% neurotic.
N=80.
Age: ~ 41 years.
Sex: all male.
History: veterans, with a service-connected neuropsychiatric disability, having spent time
in hospital (average duration of admissions 4.23 yrs), not suicidal or violent
Interventions 1. Day care centre: individual & group psychotherapy & medication, patient/staff ratio
not reported. N=40.
2. Standard outpatient care. N=40.
Outcomes Service use: admission to hospital.
Global state: number lost to follow up.
Unable to use -
Service use: days in hospital (no SD, no ITT).
Social functioning (Outpatient Adjustment Rating Scales, unpublished)
Notes
Risk of bias
Item Authors’ judgement Description
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Meltzoff 1966 (Continued)
Adequate sequence generation? Yes Randomised - 80 cards shuffled by use of
table of random numbers
Allocation concealment? Unclear Deck of cards kept in custody of research
personnel, top card drown only when name
of patient brought in. Researchers noted
42%married (outpatient) versus 27%mar-
ried (day treatment) - but no information
on how many variables they compared
Blinding?
All outcomes
Unclear Research personnel had no dealingwith pa-
tients, but patients were questioned about
their day by their assessor
Incomplete outcome data addressed?
All outcomes
Unclear Missing data on 29 interviews reported but
not explained.
Free of selective reporting? Unclear Methods described consistent with out-
comes reported, no protocol available
Free of other bias? Unclear It was not reported whether blinding was
successful. Authors did not declare sources
of support and interests in the study. 11
subjects were removed from the study after
randomisation - the reasons stated as poor
attendance or failure to attend
Weldon 1979
Methods Allocation: random - no further details.
Blindness: unclear if independent or blind to group allocation.
Duration: three months.
Setting: day hospital in New York.
Participants Diagnosis: schizophrenia.
N=30 (N assessed not known).
Age: ~ 37 years.
Sex: 9 M, 21 F.
History: recently discharged, not suicidal, violent or abusing drugs, 19 persons had two
or more previous admissions
Interventions 1. Day hospital treatment: intensive 5 days/week group therapy, recreational/prevoca-
tional activities/therapy, patient/staff ratio - 2.5. N=15.
2. Psychotherapy oriented OP care: including medication clinic. N=15
Outcomes Service use: admission to hospital.
Global state: number lost to follow up.
Social functioning: CAS, employment.
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Weldon 1979 (Continued)
Mental state: POMS, SCL-90.
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear “Randomly assigned” (no details).
Allocation concealment? Unclear No details on concealment.
Blinding?
All outcomes
No Not blinded by design.
Incomplete outcome data addressed?
All outcomes
Yes No loss to follow up.
Free of selective reporting? Unclear Methods described consistent with out-
comes reported, no protocol available
Free of other bias? Unclear Due to small sample size and short duration
of the study.
Abbreviations:
Anx - anxiety.
Behav - behavioural.
BPRS - Brief Psychiatric Rating Scale.
CAS - Community Adaptation Schedule.
Dep - depression.
DH - day hospital.
IP - Inpatient care.
IPD - individual patient data were used to calculate this outcome.
ITT - intention to treat analysis.
Meds - medication.
Mod - moderate.
OP - outpatient.
PD - personality disorder.
POMS - Profile of Mood States.
PSE - Present State Examination.
SCID - Structured Clinical Interview for DSM IIIR.
SCL - Symptom Check-List.
Scz - schizophrenia.
SD - standard deviation.
SDRS - Social Dysfunction Rating Scale.
VA - Veterans’ Administration.
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Austin 1976 Allocation: not randomised, survey comparing randomly selected subjects from two different day hospitals
Azim 1978 Allocation: not randomised, quasi-experimental design comparing outcome for patients in a day treatment
program for non-psychotic patients, with non-patient controls
Barkley 1989 Allocation: not randomised, retrospective study of admission rates at three day care centres
Basker 1986 Allocation: not randomised, before and after design.
Bateman 1999 Allocation: randomised.
Participants: people with borderline personality disorder, not people with schizophrenia
Beigel 1970 Allocation: not randomised, survey.
Bertrand 1973 Allocation: not randomised.
Boath 1999 Allocation: not randomised, quasi-experimental design.
Participants: people in a day treatment program for post-natal depression, not people with schizophrenia
Bowman 1983 Allocation: not randomised, survey.
Bradshaw 2000 Allocation: randomised.
Participants: people with schizophrenia who were long-term attenders at a day care centre.
Intervention: day care plus cognitive behavioural therapy versus day care alone, not day care versus outpatient
care
Brook 1973 Allocation: not randomised, survey.
Carey 1990 Allocation: randomised.
Participants: attenders at a day care centre who also abused substances.
Intervention: problem-solving training plus day care versus day care alone, not day hospital versus outpatient
care
Case 1991 Allocation: not randomised, retrospective study.
Comstock 1985 Allocation: not randomised, retrospective multivariate analysis
Creed 1989 Allocation: not randomised, quasi-experimental design - consecutive admissions
Creed 1990 Allocation: randomised.
Participants: people with acute psychiatric disorders requiring admission to hospital.
Intervention: acute day hospital versus inpatient care, not day hospital versus outpatient care
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(Continued)
Creed 1991 Allocation: randomised, by sealed envelope - however, trialists judged that randomisation procedure had
been compromised.
Participants: acute psychiatric patients about to be admitted to inpatient care.
Intervention: acute day hospital versus inpatient care, not day hospital versus outpatient care
Creed 1997 Allocation: randomised.
Participants: people with acute psychiatric disorders requiring admission to hospital.
Intervention: acute day hospital versus inpatient care, not day hospital versus outpatient care
Dick 1985 Allocation: randomised.
Participants: people with acute psychiatric disorders requiring admission to hospital.
Intervention: acute day hospital versus inpatient care, not day hospital versus outpatient care
Dick 1991 Allocation: randomised.
Participants: people with persistent anxiety and depression, not schizophrenia
Drake 1994 Allocation: not randomised, quasi-experimental design.
Ettlinger 1972 Allocation: not randomised, retrospective case-control study
Fink 1978 Allocation: not randomised, quasi-experimental study.
Glick 1974 Allocation: randomised.
Participants: people requiring hospital inpatient care.
Intervention: short versus long hospital admission, not day hospital versus outpatient care
Grad 1968 Allocation: not randomised, quasi-experimental design.
Gudeman 1983 Allocation: not randomised, before and after design.
Guidry 1979 Allocation: not randomised, before and after design.
Guillette 1978 Allocation: not randomised, cross-sectional study.
Guy 1969 Allocation: randomised.
Participants: people with schizophrenia, depression, neuroses in need of inpatient care did not meet criteria
of ’not acutely ill’
Herz 1971 Allocation: randomised (random number table).
Participants: people with acute psychiatric disorders admitted to inpatient care.
Intervention: acute day hospital care versus admission, not day hospital versus outpatient care
Herz 1975 Allocation: randomised.
Participants: people with acute psychiatric disorders about to be admitted to inpatient care.
Interventions: routine inpatient care versus brief inpatient care plus day care, not day hospital versus outpa-
tient care
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(Continued)
Hirsch1979 Allocation: random allocation.
Participants: people with acute psychiatric disorders about to be admitted to inpatient care.
Intervention: brief inpatient care with some transitional day hospital care versus routine inpatient care, not
day hospital versus outpatient care
Hogg 1990 Allocation: not randomised, survey.
Inch1997 Allocation: not randomised, prospective study.
Jarema 1997 Allocation: not randomised, survey.
Kandel 1981 Allocation: randomised.
Participants: adult general psychiatry patients attending a day treatment program.
Intervention: day treatment plus a small group intervention versus day treatment alone, not day hospital
versus outpatient care
Kecmanovic 1985 Allocation: not randomised, cross-sectional case-control study
Klyczek 1986 Allocation: not randomised, quasi-experimental design.
Konieczynska 1997 Allocation: not randomised, follow up study.
Kris 1965 Allocation: randomised.
Participants: people requiring admission for acute relapse of schizophrenia.
Intervention: acute day hospital versus inpatient care, not day hospital versus outpatient care
Kuldau 1977 Allocation: randomised.
Participants: inpatients about to be discharged.
Intervention: rapid discharge from inpatient care versus community transitional system (which involves
gradual discharge from hospital), not day hospital versus outpatient care
Levenson 1977 Allocation: randomised by table random numbers.
Participants: people with acute relapse of schizophrenia.
Intervention: treatment in an outpatient clinic versus hospital admission, not day hospital versus outpatient
care
Liang 1997 Allocation: not randomised, survey.
Lystad 1958 Allocation: not randomised, quasi-experimental design.
Mathai 1985 Allocation: not randomised, survey.
McDonnell 1977 Allocation: not randomised, survey.
Michaux 1969 Allocation: not randomised, quasi-experimental design.
Milne 1984 Allocation: not randomised, quasi-experimental study.
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(Continued)
Newton 1983 Allocation: not randomised.
Niskanen 1974 Allocation: not randomised, before and after design.
O’Shea 1998 Allocation: not randomised, retrospective cost-effectiveness analysis
Odenheimer 1965 Allocation: not randomised, survey.
Oka 1999 Allocation: not randomised, quasi-experimental design.
Pang 1985 Allocation: unclear.
Participants: unclear.
Intervention: partial hospitalisation versus inpatient care, not day hospital versus outpatient care
Penk 1978 Allocation: not randomised, quasi-experimental study.
Piersma 1997 Allocation: not randomised, quasi-experimental study.
Piper 1993 Allocation: randomised.
Participants: people with affective and personality disorders, not schizophrenia
Platt 1980 Allocation: randomised.
Participants: people with acute psychiatric disorders.
Intervention: admission to day hospital versus inpatient care, not day hospital versus outpatient care
Priebe 1999 Allocation: randomised.
Participants: people with severe psychosis.
Intervention: treatment changes according to patient wishes versus standard care, not day hospital versus
outpatient care
Priebe 2006 Allocation: randomised.
Participants: people with severe psychosis.
Intervention: day hospital versus inpatient care, not day hospital versus outpatient care
Priebe-MECCA-2002 Allocation: randomised.
Participants: people with severe psychosis.
Intervention: package of care within which outcomes were fed back to patients versus standard care, not day
hospital versus outpatient care
Prior 1998 Allocation: not randomised.
Participants: people with various diagnosis with anxiety as a main problem, not people with schizophrenia
Reynolds 2004 Allocation: randomised.
Participants: people with bipolar disorder, schizophrenia, depression.
Intervention: transitional discharge model versus referral to locality-based community psychiatric nurses,
not day hospital versus outpatient care
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Russell 1996 Allocation: not randomised, retrospective study.
Sandell 1993 Allocation: not randomised, cohort study.
Schene 1993 Allocation: randomised.
Participants: people with acute psychiatric disorders requiring admission to hospital.
Intervention: acute day hospital versus inpatient, not day hospital versus outpatient care
Skoda 1983 Allocation: randomised.
Participants: people with neurosis, not schizophrenia.
Sledge 1996 Allocation: randomised.
Participants: people with acute psychiatric disorders requiring admission to hospital.
Intervention: acute day hospital with crisis residence versus inpatient care, not day hospital versus outpatient
care
Takano 1995 Allocation: not randomised.
Tam 2000 Allocation: not randomised, survey.
Tantam 1989 Allocation: not randomised, quasi-experimental study (using matched controls)
Tsukahara 1998 Allocation: not randomised.
Tyrer 1979 Allocation: randomised.
Participants: people with neurotic disorders, not schizophrenia
Vaglum 1990 Allocation: not randomised, follow up study.
Vaitl 1989 Allocation: not randomised, retrospective study.
Van Den Hout 1995 Allocation: randomised.
Participants: depressed patients on a day treatment program.
Intervention: self-control therapy plus day care versus day care, not day hospital versus outpatient care
Vietze 1976 Allocation: not randomised.
Washburn 1976 Allocation: randomised.
Participants: women receiving inpatient treatment.
Intervention: continuing inpatient admission versus discharge to day patient care, not day hospital versus
outpatient care
Welburn 2000 Allocation: not randomised, quasi-experimental design.
Wiersma 1994 Allocation: randomised.
Participants: people with acute psychiatric disorders requiring admission to hospital.
Intervention: acute day hospital versus inpatient care, not day hospital versus outpatient care
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(Continued)
Wilberg 1998 Allocation: not randomised, quasi-experimental study.
Zwerling 1964 Allocation: randomised.
Participants: people with acute psychiatric disorders requiring admission to hospital.
Intervention: acute day hospital versus inpatient care, not day hospital versus outpatient care
Characteristics of studies awaiting assessment [ordered by study ID]
Dal Santo 2004
Methods Allocation: unclear.
Participants Diagnosis: unclear - “psychiatric patients”.
History: people being diverted from hospital admission.
Interventions Day hospital.
Outcomes Hospitalisation.
Notes Abstract only - more information requested June 2009.
37Day hospital versus outpatient care for people with schizophrenia (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
D A T A A N D A N A L Y S E S
Comparison 1. DAY HOSPITAL versus OUT-PATIENT CARE - NEAR OR ON DISCHARGE
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Deaths (all causes) - day
treatment centres
1 30 Risk Difference (M-H, Fixed, 95% CI) Not estimable
1.1 by 6 months 1 30 Risk Difference (M-H, Fixed, 95% CI) Not estimable
2 Service use: Admitted to hospital
during study - day treatment
centres
3 Risk Ratio (M-H, Random, 95% CI) Subtotals only
2.1 by 6 months 2 110 Risk Ratio (M-H, Random, 95% CI) 0.58 [0.26, 1.33]
2.2 by/at 12 months 2 242 Risk Ratio (M-H, Random, 95% CI) 0.68 [0.38, 1.22]
2.3 beyond 12 months 2 242 Risk Ratio (M-H, Random, 95% CI) 0.63 [0.34, 1.19]
3 Global state: 1. Number lost
to follow up - day treatment
centres / transitional day
hospital
3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
3.1 by 6 months 3 147 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.48, 1.95]
3.2 by/at 12 months 2 117 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.48, 1.95]
4 Global state: 2. Average score
(GAS, high score = good) -
transitional day hospital
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
4.1 by 6 months 1 37 Mean Difference (IV, Fixed, 95% CI) -7.90 [-15.68, -0.12]
4.2 by/at 12 months 1 37 Mean Difference (IV, Fixed, 95% CI) -4.31 [-15.24, 6.62]
5 Social functioning: 1a. Average
score (CAS, high score = bad) -
day treatment centres
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
5.1 by 6 months 1 30 Mean Difference (IV, Fixed, 95% CI) -0.03 [-0.30, 0.24]
6 Social functioning: 1b. Average
score (SAS, high score = bad) -
transitional day hospital
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
6.1 by 6 months 1 37 Mean Difference (IV, Fixed, 95% CI) 0.36 [-0.07, 0.79]
6.2 by/at 12 months 1 37 Mean Difference (IV, Fixed, 95% CI) 0.17 [-0.25, 0.59]
7 Social functioning: 2.
Unemployed - day treatment
centres
2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
7.1 by 6 months 1 30 Risk Ratio (M-H, Random, 95% CI) 0.04 [0.00, 0.62]
7.2 beyond 12 months 1 80 Risk Ratio (M-H, Random, 95% CI) 0.86 [0.69, 1.06]
8 Mental state: 1a. Average score
(PEF, high score = good) -
transitional day hospital
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
8.1 by 6 months 1 37 Mean Difference (IV, Fixed, 95% CI) 0.52 [-0.02, 1.06]
8.2 by/at 12 months 1 37 Mean Difference (IV, Fixed, 95% CI) 0.15 [-0.46, 0.76]
9 Mental state: 1b. Average score
(POMS, high score = bad) -
day treatment centres
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
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9.1 by 6 months 1 30 Mean Difference (IV, Fixed, 95% CI) 16.93 [-20.49, 54.
35]
10 Mental state: 1c. Average score
(SCL90, high score = bad) -
day treatment centres
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
10.1 by 6 months 1 30 Mean Difference (IV, Fixed, 95% CI) 0.31 [-0.20, 0.82]
Analysis 1.1. Comparison 1 DAY HOSPITAL versus OUT-PATIENT CARE - NEAR OR ON DISCHARGE,
Outcome 1 Deaths (all causes) - day treatment centres.
Review: Day hospital versus outpatient care for people with schizophrenia
Comparison: 1 DAY HOSPITAL versus OUT-PATIENT CARE - NEAR OR ON DISCHARGE
Outcome: 1 Deaths (all causes) - day treatment centres
Study or subgroup Day Treatment Out-patient
Risk
Difference Weight
Risk
Difference
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 by 6 months
Weldon 1979 0/15 0/15 100.0 % 0.0 [ -0.12, 0.12 ]
Total (95% CI) 15 15 100.0 % 0.0 [ -0.12, 0.12 ]
Total events: 0 (Day Treatment), 0 (Out-patient)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
-0.5 -0.25 0 0.25 0.5
Favours treatment Favours control
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Analysis 1.2. Comparison 1 DAY HOSPITAL versus OUT-PATIENT CARE - NEAR OR ON DISCHARGE,
Outcome 2 Service use: Admitted to hospital during study - day treatment centres.
Review: Day hospital versus outpatient care for people with schizophrenia
Comparison: 1 DAY HOSPITAL versus OUT-PATIENT CARE - NEAR OR ON DISCHARGE
Outcome: 2 Service use: Admitted to hospital during study - day treatment centres
Study or subgroup Day treatment Out-patient Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 by 6 months
Meltzoff 1966 7/40 12/40 100.0 % 0.58 [ 0.26, 1.33 ]
Weldon 1979 0/15 0/15 Not estimable
Subtotal (95% CI) 55 55 100.0 % 0.58 [ 0.26, 1.33 ]
Total events: 7 (Day treatment), 12 (Out-patient)
Heterogeneity: not applicable
Test for overall effect: Z = 1.28 (P = 0.20)
2 by/at 12 months
Linn 1979 32/80 38/82 68.4 % 0.86 [ 0.61, 1.23 ]
Meltzoff 1966 9/40 19/40 31.6 % 0.47 [ 0.24, 0.92 ]
Subtotal (95% CI) 120 122 100.0 % 0.68 [ 0.38, 1.22 ]
Total events: 41 (Day treatment), 57 (Out-patient)
Heterogeneity: Tau2 = 0.11; Chi2 = 2.49, df = 1 (P = 0.11); I2 =60%
Test for overall effect: Z = 1.29 (P = 0.20)
3 beyond 12 months
Linn 1979 44/80 55/82 71.2 % 0.82 [ 0.64, 1.05 ]
Meltzoff 1966 10/40 23/40 28.8 % 0.43 [ 0.24, 0.79 ]
Subtotal (95% CI) 120 122 100.0 % 0.63 [ 0.34, 1.19 ]
Total events: 54 (Day treatment), 78 (Out-patient)
Heterogeneity: Tau2 = 0.16; Chi2 = 3.90, df = 1 (P = 0.05); I2 =74%
Test for overall effect: Z = 1.42 (P = 0.15)
0.05 0.2 1 5 20
Favours day treatment Favours out-patient
40Day hospital versus outpatient care for people with schizophrenia (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.3. Comparison 1 DAY HOSPITAL versus OUT-PATIENT CARE - NEAR OR ON DISCHARGE,
Outcome 3 Global state: 1. Number lost to follow up - day treatment centres / transitional day hospital.
Review: Day hospital versus outpatient care for people with schizophrenia
Comparison: 1 DAY HOSPITAL versus OUT-PATIENT CARE - NEAR OR ON DISCHARGE
Outcome: 3 Global state: 1. Number lost to follow up - day treatment centres / transitional day hospital
Study or subgroup Day Treatment Out-patient Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 by 6 months
Glick 1986 5/19 8/18 67.3 % 0.59 [ 0.24, 1.47 ]
Meltzoff 1966 7/40 4/40 32.7 % 1.75 [ 0.56, 5.51 ]
Weldon 1979 0/15 0/15 Not estimable
Subtotal (95% CI) 74 73 100.0 % 0.97 [ 0.48, 1.95 ]
Total events: 12 (Day Treatment), 12 (Out-patient)
Heterogeneity: Chi2 = 2.14, df = 1 (P = 0.14); I2 =53%
Test for overall effect: Z = 0.08 (P = 0.93)
2 by/at 12 months
Glick 1986 5/19 8/18 67.3 % 0.59 [ 0.24, 1.47 ]
Meltzoff 1966 7/40 4/40 32.7 % 1.75 [ 0.56, 5.51 ]
Subtotal (95% CI) 59 58 100.0 % 0.97 [ 0.48, 1.95 ]
Total events: 12 (Day Treatment), 12 (Out-patient)
Heterogeneity: Chi2 = 2.14, df = 1 (P = 0.14); I2 =53%
Test for overall effect: Z = 0.08 (P = 0.93)
0.01 0.1 1 10 100
Favours Treatment Favours Control
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Analysis 1.4. Comparison 1 DAY HOSPITAL versus OUT-PATIENT CARE - NEAR OR ON DISCHARGE,
Outcome 4 Global state: 2. Average score (GAS, high score = good) - transitional day hospital.
Review: Day hospital versus outpatient care for people with schizophrenia
Comparison: 1 DAY HOSPITAL versus OUT-PATIENT CARE - NEAR OR ON DISCHARGE
Outcome: 4 Global state: 2. Average score (GAS, high score = good) - transitional day hospital
Study or subgroup Day Treatment Out-patient
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 by 6 months
Glick 1986 19 47 (13.69) 18 54.9 (10.29) 100.0 % -7.90 [ -15.68, -0.12 ]
Subtotal (95% CI) 19 18 100.0 % -7.90 [ -15.68, -0.12 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.99 (P = 0.046)
2 by/at 12 months
Glick 1986 19 51.29 (15.21) 18 55.6 (18.45) 100.0 % -4.31 [ -15.24, 6.62 ]
Subtotal (95% CI) 19 18 100.0 % -4.31 [ -15.24, 6.62 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.77 (P = 0.44)
Test for subgroup differences: Chi2 = 0.28, df = 1 (P = 0.60), I2 =0.0%
-50 -25 0 25 50
Favours treatment Favours control
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Analysis 1.5. Comparison 1 DAY HOSPITAL versus OUT-PATIENT CARE - NEAR OR ON DISCHARGE,
Outcome 5 Social functioning: 1a. Average score (CAS, high score = bad) - day treatment centres.
Review: Day hospital versus outpatient care for people with schizophrenia
Comparison: 1 DAY HOSPITAL versus OUT-PATIENT CARE - NEAR OR ON DISCHARGE
Outcome: 5 Social functioning: 1a. Average score (CAS, high score = bad) - day treatment centres
Study or subgroup Day Treatment Out-patient
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 by 6 months
Weldon 1979 15 3.49 (0.33) 15 3.52 (0.43) 100.0 % -0.03 [ -0.30, 0.24 ]
Subtotal (95% CI) 15 15 100.0 % -0.03 [ -0.30, 0.24 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.21 (P = 0.83)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours Treatment Favours Control
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Analysis 1.6. Comparison 1 DAY HOSPITAL versus OUT-PATIENT CARE - NEAR OR ON DISCHARGE,
Outcome 6 Social functioning: 1b. Average score (SAS, high score = bad) - transitional day hospital.
Review: Day hospital versus outpatient care for people with schizophrenia
Comparison: 1 DAY HOSPITAL versus OUT-PATIENT CARE - NEAR OR ON DISCHARGE
Outcome: 6 Social functioning: 1b. Average score (SAS, high score = bad) - transitional day hospital
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 by 6 months
Glick 1986 19 2.38 (0.59) 18 2.02 (0.74) 100.0 % 0.36 [ -0.07, 0.79 ]
Subtotal (95% CI) 19 18 100.0 % 0.36 [ -0.07, 0.79 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.63 (P = 0.10)
2 by/at 12 months
Glick 1986 19 2.29 (0.45) 18 2.12 (0.8) 100.0 % 0.17 [ -0.25, 0.59 ]
Subtotal (95% CI) 19 18 100.0 % 0.17 [ -0.25, 0.59 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.79 (P = 0.43)
Test for subgroup differences: Chi2 = 0.38, df = 1 (P = 0.54), I2 =0.0%
-1 -0.5 0 0.5 1
Favours treatment Favours control
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Analysis 1.7. Comparison 1 DAY HOSPITAL versus OUT-PATIENT CARE - NEAR OR ON DISCHARGE,
Outcome 7 Social functioning: 2. Unemployed - day treatment centres.
Review: Day hospital versus outpatient care for people with schizophrenia
Comparison: 1 DAY HOSPITAL versus OUT-PATIENT CARE - NEAR OR ON DISCHARGE
Outcome: 7 Social functioning: 2. Unemployed - day treatment centres
Study or subgroup Day treatment Out-patient Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 by 6 months
Weldon 1979 0/15 12/15 100.0 % 0.04 [ 0.00, 0.62 ]
Subtotal (95% CI) 15 15 100.0 % 0.04 [ 0.00, 0.62 ]
Total events: 0 (Day treatment), 12 (Out-patient)
Heterogeneity: not applicable
Test for overall effect: Z = 2.30 (P = 0.021)
2 beyond 12 months
Meltzoff 1966 30/40 35/40 100.0 % 0.86 [ 0.69, 1.06 ]
Subtotal (95% CI) 40 40 100.0 % 0.86 [ 0.69, 1.06 ]
Total events: 30 (Day treatment), 35 (Out-patient)
Heterogeneity: not applicable
Test for overall effect: Z = 1.41 (P = 0.16)
0.002 0.1 1 10 500
Favours day treatment Favours out-patients
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Analysis 1.8. Comparison 1 DAY HOSPITAL versus OUT-PATIENT CARE - NEAR OR ON DISCHARGE,
Outcome 8 Mental state: 1a. Average score (PEF, high score = good) - transitional day hospital.
Review: Day hospital versus outpatient care for people with schizophrenia
Comparison: 1 DAY HOSPITAL versus OUT-PATIENT CARE - NEAR OR ON DISCHARGE
Outcome: 8 Mental state: 1a. Average score (PEF, high score = good) - transitional day hospital
Study or subgroup Day Treatment Out-patient
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 by 6 months
Glick 1986 19 3.42 (0.79) 18 2.9 (0.88) 100.0 % 0.52 [ -0.02, 1.06 ]
Subtotal (95% CI) 19 18 100.0 % 0.52 [ -0.02, 1.06 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.89 (P = 0.059)
2 by/at 12 months
Glick 1986 19 3.25 (0.75) 18 3.1 (1.1) 100.0 % 0.15 [ -0.46, 0.76 ]
Subtotal (95% CI) 19 18 100.0 % 0.15 [ -0.46, 0.76 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.48 (P = 0.63)
Test for subgroup differences: Chi2 = 0.79, df = 1 (P = 0.37), I2 =0.0%
-4 -2 0 2 4
Favours treatment Favours control
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Analysis 1.9. Comparison 1 DAY HOSPITAL versus OUT-PATIENT CARE - NEAR OR ON DISCHARGE,
Outcome 9 Mental state: 1b. Average score (POMS, high score = bad) - day treatment centres.
Review: Day hospital versus outpatient care for people with schizophrenia
Comparison: 1 DAY HOSPITAL versus OUT-PATIENT CARE - NEAR OR ON DISCHARGE
Outcome: 9 Mental state: 1b. Average score (POMS, high score = bad) - day treatment centres
Study or subgroup Day Treatment Out-patient
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 by 6 months
Weldon 1979 15 182.93 (51.75) 15 166 (52.81) 100.0 % 16.93 [ -20.49, 54.35 ]
Subtotal (95% CI) 15 15 100.0 % 16.93 [ -20.49, 54.35 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.89 (P = 0.38)
Test for subgroup differences: Not applicable
-50 -25 0 25 50
Favours Treatment Favours Control
Analysis 1.10. Comparison 1 DAY HOSPITAL versus OUT-PATIENT CARE - NEAR OR ON DISCHARGE,
Outcome 10 Mental state: 1c. Average score (SCL90, high score = bad) - day treatment centres.
Review: Day hospital versus outpatient care for people with schizophrenia
Comparison: 1 DAY HOSPITAL versus OUT-PATIENT CARE - NEAR OR ON DISCHARGE
Outcome: 10 Mental state: 1c. Average score (SCL90, high score = bad) - day treatment centres
Study or subgroup Day Treatment Out-patient
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 by 6 months
Weldon 1979 15 1.09 (0.73) 15 0.78 (0.7) 100.0 % 0.31 [ -0.20, 0.82 ]
Subtotal (95% CI) 15 15 100.0 % 0.31 [ -0.20, 0.82 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.19 (P = 0.24)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours Treatment Favours Control
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A D D I T I O N A L T A B L E S
Table 1. Suggested design for future study
Methods Allocation: randomised, clearly described.
Follow up: three years.
Blindness: blinded rates, blindness tested.
Analysis: intention-to-treat.
Participants Diagnosis: schizophrenia (clinical diagnosis).
N=300.
Age: adults.
Sex: both.
History: recently discharged.
Interventions 1. Day hospital care - medication management, supportive & group therapy;
recreational activities, group therapy, counselling, occupational therapy, medication follow up,
patient/staff ratio clearly reported.
2. Outpatient care - OP drug management no other aftercare.
Outcomes Primary outcomes.
1. Service use.
1.1 Mean number of days per month in hospital.
Secondary outcomes.
1. Death - suicide and all causes.
2. Service use.
2.1 Hospitalisation: Admitted to hospital across time.
2.2 Hospitalisation: Number of admissions across time.
2.3 Use of services outside of mental health provision (i.e. emergency services)
3. Global state.
3.1 Leaving the study early (lost to follow up).
3.2 Relapse.
3.3 Compliance with medication.
4. Social functioning.
4.1 Imprisonment (i.e. police contacts and arrests).
4.2 Employment status (number unemployed at end of study).
5. Behaviour
5.1 Specific behaviours (i.e. self-harm; injury to others or property)
6. Quality of life.
6.1 Number of healthy days.
6.2 Satisfaction with care.
7. Economic: costs of care (taking into account cost of inpatient stay)
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A P P E N D I C E S
Appendix 1. Search used for previous version of this review (2001)
Electronic searches
The search began by deriving a list of search terms from reading overviews of the field and consulting experts in day hospital care. The
reference databases listed below were searched.
1. CINAHL (January 1982 - December 2000) was searched using the Cochrane Schizophrenia Group’s search strategy for randomised
controlled trials combined with the phrase:
[((DAY adj2HOSP*) or (DAY adj2CARE) or (DAY adj2TREATMENT*) or (DAY adj2CENT*) or (DAY adj2UNIT*) or (PARTIAL
adj2 HOSP*) or (DISPENSARY)) AND MENTAL DISORDERS].
2. The Cochrane Library (Issue 4, 2000) was searched using the phrases:
[((DAYnearHOSP*) or (DAYnearCARE) or (DAYnear TREATMENT*) or (DAY nearCENT*) or (DAY nearUNIT*) or (PARTIAL
near HOSP*) or (DISPENSARY)) ANDMENTAL DISORDERS exploded].
3. EMBASE (January 1980 - December 2000) was searched using the Cochrane Schizophrenia Group’s search strategy for randomised
controlled trials combined with the phrase:
[AND ((DAY adj2 HOSP*) or (DAY adj2 CARE) or (DAY adj2 TREATMENT*) or (DAY adj2 CENT*) or (DAY adj2 UNIT*) or
(PARTIAL adj2 HOSP*) or (DISPENSARY)) AND MENTAL DISORDERS].
4. MEDLINE (January 1966 -December 2000) was searched using the Cochrane Schizophrenia Group’s search strategy for randomised
controlled trials combined with the phrase:
[AND ((DAY adj2 HOSP*) or (DAY adj2 CARE) or (DAY adj2 TREATMENT*) or (DAY adj2 CENT*) or (DAY adj2 UNIT*) or
(PARTIAL adj2 HOSP*) or (DISPENSARY)) AND MENTAL DISORDERS/All subheadings exploded].
5. PsycLIT (January 1967 - December 2000) was searched using the Cochrane Schizophrenia Group’s search strategy for randomised
controlled trials combined with the phrase:
[AND ((DAY adj2 HOSP*) or (DAY adj2 CARE) or (DAY adj2 TREATMENT*) or (DAY adj2 CENT*) or (DAY adj2 UNIT*) or
(PARTIAL adj2 HOSP*) or (DISPENSARY)) AND MENTAL DISORDERS].
Searching other resources
1. Reference searching
The sensitivity of the search strategy was examined by comparing the results of the search with the reference lists of the identified
reviews and trials, but no new trials were identified.
2. Personal contact
Researchers in the field were approached to identify unpublished studies
Appendix 2. Methods used in previous version of this review (2001)
Methods
Criteria for considering studies for this review
Types of studies
Eligible studies were randomised controlled trials comparing day hospital care (including day treatment programme, day care centre
and transitional day care) against outpatient care.
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Types of participants
For studies of day treatment programmes, participants were patients with non-psychotic disorders (all diagnoses) who would have been
treated in outpatient care had day hospital care not been available. It was not necessary for participants to be “refractory to outpatient
treatment”, as there is no generally agreed definition of this term. However, the review recorded the entry criteria for each day treatment
programme and took these into consideration in the analysis of results.
For studies of day care centres, participants were patients with severe long-term disorders (predominantly schizophrenia and other
psychoses) who would have been followed up in outpatient care had day hospital care not been available.
For studies of transitional day care, participants were inpatients on acute psychiatric wards, who would have been discharged to
outpatient care had ’transitional day care’ not been available.
Studies were not eligible if they were restricted to, or included a majority of, patients who were aged under 18 or over 65, or had a
primary diagnosis of substance abuse or organic brain disorder.
Types of interventions
1. Day treatment programmes were defined as: “psychiatric day hospitals (see above) offering intensive input to patients with non-
psychotic disorders”.
2. Day care centres were defined as “psychiatric day hospitals offering continuing care to patients with severe mental disorders”.
3. Transitional day hospitals were defined as “psychiatric day hospitals offering time-limited care to patients discharged from inpatient
care”.
4. Standard outpatient care.
Types of outcome measures
Primary outcomes
1. Readmission to hospital
1.1 number admitted to inpatient care
Secondary outcomes
1. Engagement with treatment
1.1 number lost to follow up.
2. Readmission to hospital:
2.1 mean days in inpatient care
3. Clinical outcomes
3.1 mental state
3.2 social functioning
3.3 quality of life
3.4 death
3.5 burden on relatives
3.6 satisfaction with care
4. Cost of care
4.1 mean monthly cost of psychiatric care (comprising cost of hospital care plus cost of all ambulatory psychiatric care)
4.2 mean monthly cost of all care (comprising cost of psychiatric care plus costs of other medical/social care, but excluding wages, costs
to relatives, and transfer payments).
For day treatment programmes two additional outcomes were included: (1) number refusing to enter trial because unwilling to attend
day hospital; and (2) self harm/self mutilation.
Search methods for identification of studies
Search methods used in the previous version of this review are reproduced in Appendix 1.
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Data collection and analysis
1. Selection of trials
Abstracts of the ’hits’ identified in the searchwere inspected independently by two reviewers (MMand AA). Potentially relevant abstracts
were identified (i.e. those in which a group of day hospital patients meeting the patient inclusion criteria were compared against a
control group) and full papers ordered. A reliability study found complete agreement on which trials met inclusion criteria.
2. Assessment of quality
Each reviewer allocated the included trials to one of three categories of allocation concealment, as described in the Cochrane Collabo-
ration Handbook (Clarke 2000). Disagreements were resolved by discussion, or failing this, by seeking further information from the
trialists. Only trials in Category A or B were included in the review (i.e. randomised trials where method of allocation concealment was
either adequate or unclear). Trials were also rated on degree of blindness. Blinding of patients and treating clinicians is not possible in
a trial of day hospital treatment, but trials were rated on independence and blinding of evaluators (non-independent evaluators being
defined as being also involved in the treatment of trial patients).
3. Data collection
Data were extracted independently by three reviewers (MM, AA and RC) and cross-checked. Where further clarification was needed
the authors of trials were contacted to provide missing data.
4. Data synthesis
4.1 Incomplete data
Data were excluded if they could not be analysed on an intention-to-treat basis, for example if there was exclusion of subjects post-
randomisation for reasons other than loss to follow up. Data were also excluded from studies where more than 50% of subjects were
lost to follow up (except for the outcome of ’lost to follow up’).
4.2 Binary data
For binary outcomes a standard estimation of the risk ratio (RR) and its 95% confidence interval (CI) was calculated. If the relative risk
was significant, the number needed to treat statistic (NNT) was also calculated. If heterogeneity was found (see section 5) a random-
effects model was used.
4.3 Continuous data
4.3.1 Summary statistic: for continuous outcomes a weighted mean difference (WMD) between groups was estimated. Continuous
data presented without use of summary statistics (i.e. mean, SD/SE or non-parametric equivalent) were not considered good evidence,
though the existence of such data was noted in the text.
4.3.2 Valid scales: unpublished scales are known to be subject to bias in trials of treatments for schizophrenia (Marshall 2000). Therefore
continuous data from rating scales were included only if the measuring instrument had been described in a peer-reviewed journal and
the instrument was either a self report or completed by an independent evaluator or relative (not the therapist).
4.3.3 Individual patient data: individual patient data were not sought for this review, however one author (PT) provided individual
patient data. These data were verified against the original trial reports, and permitted a rating of social functioning to be upgraded from
a mention in the text to an entry on RevMan (as summary statistics were then available). Exclusion of these data do not alter the main
conclusions of the review.
5. Test for heterogeneity
A Chi-square test was used, as well as visual inspection of graphs, to investigate the possibility of heterogeneity. A significance level less
than 0.10 was interpreted as evidence of heterogeneity. If heterogeneity was found the data were re-analysed using a random-effects
model. If this made a substantial difference, the studies responsible for the heterogeneity were presented separately from the main body
of homogeneous trials and the reasons for heterogeneity were investigated.
6. Addressing publication bias
There were insufficient data to address the question of publication bias. Had sufficient data been available, they would have been
entered into a funnel graph (trial effect against trial size) in an attempt to investigate the likelihood of overt publication bias (Egger
1997).
7. Sensitivity analyses
Sensitivity analyses were not performed for lack of adequate data (see results below). With more data, sensitivity analyses would have
been used to examine the effect of excluding studies with (a) high attrition rates (>75%); (b) non-independent or non-blind raters; and
(c) allocation concealment in category B.
8. General
Where possible, reviewers entered data so that the area to the left of the line of no effect indicated a favourable outcome for the
intervention (i.e. day treatment programme or day care centre).
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WH A T ’ S N E W
Last assessed as up-to-date: 17 May 2009.
Date Event Description
6 October 2010 Amended Contact details updated.
H I S T O R Y
Protocol first published: Issue 4, 1997
Review first published: Issue 3, 2001
Date Event Description
14 April 2010 Amended Contact details updated.
15 February 2010 Amended Contact details updated.
12 August 2009 New citation required but conclusions have not
changed
Completely restructured, entry criteria is changed.
12 August 2009 New search has been performed Completely restructured, entry criteria is changed, title
changed to focus on people with schizophrenia
23 October 2008 Amended Converted to new review format.
C O N T R I B U T I O N S O F A U T H O R S
Elena Shek - updated the review in 2009 - updated methods, co-ordinated the review, undertook searches, screened search results,
appraised papers, extracted data, entered them into RevMan, analysed data, interpreted the findings and took a lead in writing the final
report of 2009.
Airton Stein - updated review in 2009 - updated methods, screened search results, cross-checked data extraction, helped interpret
findings and write the report.
Flavio Shansis - updated review in 2009 - updated methods, screened search results, cross-checked data extraction, helped interpret
findings and write the report.
Max Marshall - led first version of the review, designed original methods, co-ordinated the review, collected data, undertook search
strategy, screened search results, appraised papers, extracted data, compiled individual patient data, cross-checked these data against
trial reports, analysed data, interpreted the data and wrote the report of 2001. In the 2009 update helped advise on methods and write
final report.
Ruth Crowther - worked solely on first version of review - helped co-ordinate review, collect data, cross-check data extraction, manage
data, entered them into RevMan, compiled individual patient data, cross-checked them against trial reports, analysed data, interpreted
them and helped write the original report
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Peter Tyrer - worked mainly on first version of review - prepared and provided individual patient data, helped analyse data, interpret
results and write final report.
D E C L A R A T I O N S O F I N T E R E S T
None known. Peter Tyrer has undertaken a trial of day hospital treatment but this was for participants not relevant to the 2009 update
of this review and therefore has been excluded.
S O U R C E S O F S U P P O R T
Internal sources
• Institute of Clinical Research India, Bangalore, India.
• School of Health, Cranfield University, UK.
• Universidade Federal de Ciências da Saúde, Porto Alegre, Brazil.
• Ulbra and Grupo Hospitalar Conceição, Porto Alegre, Brazil.
• Sao Pedro Hospital, Porto Alegre, Brazil.
External sources
• No sources of support supplied
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
This is an update of an old review and with that comes a major revision of the methods from the earlier version. The ’methods’ section
of the first version of this review is appended (Appendix 2).
I N D E X T E R M S
Medical Subject Headings (MeSH)
Aftercare; AmbulatoryCare [standards]; DayCare,Medical [economics; ∗standards];Hospitals, Psychiatric;Mental Disorders [therapy];
Program Evaluation; Randomized Controlled Trials as Topic; Schizophrenia [∗therapy]
MeSH check words
Humans
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